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ABSTRACT: The conjugation of biomolecules can impart materials with the
bioactivity necessary to modulate speciﬁc cell behaviors. While the biological roles of
particular polypeptide, oligonucleotide, and glycan structures have been extensively
reviewed, along with the inﬂuence of attachment on material structure and function, the
key role played by the conjugation strategy in determining activity is often overlooked.
In this review, we focus on the chemistry of biomolecule conjugation and provide a
comprehensive overview of the key strategies for achieving controlled biomaterial
functionalization. No universal method exists to provide optimal attachment, and here
we will discuss both the relative advantages and disadvantages of each technique. In
doing so, we highlight the importance of carefully considering the impact and suitability
of a particular technique during biomaterial design.
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1. INTRODUCTION
The use of biomaterials to stimulate the repair, regrowth, or
replacement of damaged biological tissue has emerged as a vital
tool in the treatment and prevention of disease.1−6
Biomaterial-based technologies typically take the form of
cellular or acellular scaﬀolds for implantation in vivo, or
alternatively platforms to support the in vitro growth of tissue
for subsequent grafting.6 A key challenge in biomaterial design
is the creation of structures able to mimic or supplement the
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cues provided by the native extracellular matrix (ECM).7−9 By
doing so, cellular growth, inﬁltration, diﬀerentiation, and
signaling can be controlled in order to aid tissue development
and generate a successful clinical outcome. The processing of
scaﬀolds to recreate the physical or topological features of
native tissue,8,10 the synthesis of polymers which mimic the
chemical characteristics of ECM,11,12 and the incorporation of
functional components which bind and manipulate minerals
and biomolecules in vivo13,14 can all be used to direct cell
behavior. However, the installation of motifs able to provide
biochemical stimuli remains the most powerful means to
inﬂuence growing tissue. The functionalization of scaﬀolds
with active biomolecules is therefore of particular interest to
generate eﬀective materials for regenerative medicine.
Proteins and signaling peptides present within the
extracellular environment play a vital role in determining and
regulating a wide range of cellular behaviors. The tethering of
peptides and proteins to a core structural component has
therefore found widespread use as a method for endowing both
synthetic and naturally derived materials with the bioactive
properties required for successful clinical translation.15−17
Similarly, glycans within the extracellular environment are
inﬂuential in controlling cellular processes, acting to mediate
signaling, adhesion, and traﬃcking.18,19 To date, the formation
of glyco-conjugates has been an underutilized tool in the ﬁeld
of biomaterial design. However, with rapidly improving
appreciation of the importance of glycobiology and increasing
progress in the synthesis of complex oligosaccharides,
carbohydrate-functionalized materials are becoming more
prominent.20,21 Finally, the use of oligonucleotide-conjugates
as a means to impart bioinstructive properties on a material has
emerged as a signiﬁcant area of research in recent years.22,23
While the natural roles of deoxyribonucleic acid (DNA) and
ribonucleic acid (RNA) sequences are diﬃcult to exploit when
tethered in the extracellular environment, the structural and
functional capabilities of non-natural and evolved sequences
are increasingly being employed in biomaterial design. In
particular, aptamer sequences able to bind strongly to a target
of interest have been used as a means to control the deposition
of regenerative proteins, recruit endogenous growth factors,
and control cell-selective adhesion.24−26
Biomolecule-material conjugates are able to play a diverse
role in recreating the native extracellular niche, promoting
cellular adhesion, providing degradable linkers for scaﬀold
remodeling, controlling cell signaling for tissue growth or
diﬀerentiation, or acting to sequester and provide structure to
deposited matrix.27,28 The biological roles of polypeptide,
glycan, and oligonucleotide conjugates and the inﬂuence of
particular sequences and structures on biological behavior have
been reviewed extensively.18,19,23,27−30 Similarly the choice of
core scaﬀold material, topological and physical eﬀects on cell
behavior, and the inﬂuence of biomaterial degradability and
plasticity are equally well documented.7,8,31−35 Although
brieﬂy covered here as an introduction to the ﬁeld, the reader
is therefore directed to these excellent and comprehensive
reviews for further information.
In this review we will focus on the chemistry used to
produce biomolecule-biomaterial conjugates (Figure 1). This
Figure 1. Key covalent methods by which biomolecule-material conjugation can be achieved. Each shall be discussed in detail during this review.
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important aspect of biomaterial design is often overlooked,
despite playing a key role in inﬂuencing bioactivity and
construct performance. There is no single optimal method for
conjugation, and it is important to consider carefully the
impact and suitability of a particular technique before
embarking on the production of a functionalized device.17
Key factors including the site-selectivity of conjugation,
eﬃciency and rate of reaction, orthogonality to other
modiﬁcations, ability to provide biomolecule patterning, and
accessibility of reaction partners must all be considered.36 The
concept of selective-conjugation will be a common theme
throughout the discussion, particularly in the context of
peptide and protein conjugation. It has been widely shown that
favorable surface orientation is essential to maximize
bioactivity.37−39 Modiﬁcation strategies that are able to target
a uniquely reactive amino acid are thus particularly power-
ful.39−43
It is important that a particular conjugation method is
carefully matched to the core material and end application, and
what is best in one scenario may prove to be entirely
inadequate for another. Here, we therefore aim to provide a
comprehensive overview of the diﬀerent reactions and
conjugation techniques that may be utilized to tether
polypeptides, glycans, and oligonucleotides to biomaterial
scaﬀolds. We will focus on the advantages and disadvantages of
each technique, including the selectivity and sequence
speciﬁcity provided by each method and their ease of use.
We envisage that this work will provide both a useful guide for
those looking to enter the ﬁeld, as well as a detailed resource
for experienced researchers. By doing so, we hope to stimulate
the design and production of new biomaterial systems with
enhanced bioactivity and eﬃcacy, as well as encouraging the
use of new or overlooked conjugation techniques in the tissue
engineering ﬁeld which may overcome the shortcomings of
existing methods.
2. LAYOUT OF THE REVIEW
This review will be split broadly into four sections: chemical-,
enzymatic-, photo-, and noncovalent conjugations (Figure 1).
Although all of the techniques discussed in this review could be
considered “chemical” in nature, here we utilize the term more
speciﬁcally to describe reactions that rely on the chemical
reaction between the conjugation components to generate a
covalent linkage, without the need for exogenous biological or
physical stimuli (e.g., enzymes or light). Many of the
techniques described take inspiration from more general
reports in the absence of biomaterials or biomolecules. A
timeline outlining these key developments, as well as their
application for biomaterial functionalization over the last 20
years is provided in Figure 2. We will brieﬂy discuss this key
preceding literature, setting the scene for a detailed discussion
of the uses and limitations of biomolecule conjugation
strategies for biomaterial functionalization. Finally, we will
summarize the key ﬁndings enabled by each technology where
relevant. For more detailed discussions on the applications of
the developed materials in the tissue engineering ﬁeld, as well
as the wider impact of particular modiﬁcation strategies outside
of this area, the reader will be directed to key reviews
throughout. At the end of each section we provide a table
summarizing the major pros and cons of each conjugation
strategy, as well as details of selectivity and orthogonality to
other methods (Tables 1−4).
3. CHALLENGES IN SELECTIVITY
Biomolecule functionalization strategies can be broadly split
into two categories: those which target a speciﬁc site for
modiﬁcation and those which modify multiple groups
indiscriminately. This idea of “site-selectivity” is a key concept
in biomolecule conjugation which will be considered
throughout this review. It plays a crucial role in determining
biological activity, conjugation eﬃciency, ease of use, and
device reproducibility.36,44,45 To demonstrate this, we can
consider a hypothetical protein containing 10 surface-exposed
Figure 2.Major developments in biomaterial functionalization over the past 20 years. Many conjugation techniques have ﬁrst been reported for the
functionalization of proteins with small molecules, before later being translated to biomaterial derivatization.
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lysines and a single cysteine. Methods to functionalize a
material via these lysine residues are typically straightforward;
however, they will also result in a heterogeneous mixture of at
least 10 diﬀerent protein orientations, before we begin to
consider more complex scenarios in which multiple lysines are
modiﬁed within a single protein. While some of these
conformations might maintain activity, others may possess
hindered or blocked active sites or deformed protein
structures. The importance of favorable orientation and
geometry following material tethering has been widely
reported, particularly for protein and glycans, and is a crucial
factor aﬀecting biological eﬃcacy.37−39,46,47
In contrast, if we instead target the single cysteine via a site-
selective reaction homogeneous constructs will be produced. If
the site of modiﬁcation tolerates alteration and is located in a
way to expose the key active regions of the protein, then we
can expect to maintain activity in a way that is unlikely to be
achieved via nonselective strategies. However, it is important
to note that the opposite can also prove true; if the cysteine is
crucial to activity, our attempts to achieve selectivity may
instead lead to drastic loss of activity. Selective modiﬁcation
strategies are therefore an important means through which to
maximize device performance but require careful planning and
design to implement.36 Whether the increased complexity
provides suﬃcient strategic beneﬁt is something that must be
considered on a case by case basis.
Diﬃculties in achieving selectivity originate from the limited
diversity of chemical functionality that exists in native
biomolecules. Methods exist to functionalize the amines,
alcohols, and carboxylic acids that make up the bulk of
functional groups in amino acids, monosaccharides, and
nucleotides, but typically a large number of each reactive
handle are present in any given biomolecule.48 The rarity of
the thiol side group of cysteine in polypeptides partially
Table 1. Advantages, Disadvantages, and Selectivity of the Chemical Conjugation Strategies Outlined in Sections 4 and 6
conjugation strategy advantages disadvantages selectivity
amide formation ease of use site-selectivity very low selective for amines and carboxylic acids
high reagent availability side-reactions aﬀect yield
requires no prior engineering poor tolerance of water
robust and reliable leads to heterogeneous products
reductive amination good chemo-selectivity slow kinetics selective for amines and aldehydes/ketones
ease of use site-selectivity very low tolerant of other groups
aldehydes often easily introduced into
materials
aldehydes potentially toxic
thiol Michael
addition
rapid conjugation potentially reversible side-reactions with amines necessitates careful
control
tunable reaction kinetics maleimides undergo hydrolysis
low occurrence of cysteine enhances
selectivity
thiols often key for bioactivity
ease of introduction disulﬁdes form over time
robust protocols for use
disulﬁde formation ease of use very slow high selectivity for thiols
easy to trigger cleavage form mixed or homodisulﬁdes prone to formation of mixed or homodisulﬁdes
CuAAC high chemo-selectivity copper potentially toxic very high selectivity for azides and alkynes
reactive groups absent from native
biomolecules
azide/alkynes must be introduced into
biomolecule
copper chelated by many functional groups
functional groups readily accessible high catalyst loadings often needed activated alkynes prone to thiol−yne reaction
SPAAC requires no added catalyst alkynes hard to synthesize/expensive generally high selectivity for azides and strained
alkynes
ease of use alkynes are highly hydrophobic cyclooctynes undergo side reaction with thiols
kinetics can be tuned by alkyne structure kinetics slow compared to IEDDA
reactive groups absent from native
biomolecules
azide/alkynes must be introduced into
biomolecule
very low toxicity
IEDDA very fast kinetics some tetrazines unstable high selectivity for strained alkenes and tetrazines
reactive groups absent from native
biomolecules
fastest alkenes diﬃcult to access and
hydrophobic
cyclooctenes can be isomerized by presence of
thiols
high selectivity alkene/tetrazine must be introduced
into biomolecule
oxime/hydrazone
formation
dynamic conjugation low stability if reversibility not desired equilibrium with imine formation is dominated by
hydrazones/oximes.
hydrazines and hydroxylamines absent from
biomolecules
catalysts needed to boost kinetics tolerant of other groups
aldehydes often easily introduced aldehydes potentially toxic
reactive groups must be introduced
Free-radical
polymerization
high tolerance of functional groups deoxygenation necessary tolerant of most functional groups
widely used in biomaterial ﬁeld polymerizations and excess monomer
often toxic
cross reactivity with Michael addition and IEDDA
reactive handles
allows conjugation during material
formation
radicals damaging to biomolecules
excess reactive handles can be used for
further conjugation
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mitigates this problem but comes with its own limitations that
will be discussed in section 4.2.49 Three approaches are
therefore primarily used by researchers to undertake site-
selective bioconjugation:
(i) Modiﬁcation strategies that can select a single motif
among many, rather than targeting a generic reactive
handle. This is often determined by surrounding
sequence, local environment, or subtle diﬀerences in
reactivity. The ability of enzymes to modify a speciﬁc
amino acid within a protein sequence or a glycan at a
single position are particularly prominent examples and
will be the focus of section 5. Reactions that display
exquisite chemo-selectivity also fall within this category,
such as those that target the unique reactivity of the
protein N-terminus or the anomeric position of glycans.
(ii) The site-speciﬁc incorporation of unnatural function-
alities, by hijacking native biosynthetic pathways.50
Developments over the past 20 years have led to
technologies through which uniquely reactive residues
can be selectively installed. Such systems will be
described in more detail in section 10.
(iii) The installation of unique reactivity via chemical
synthesis. The complete or partial synthesis of peptides
and oligonucleotides is widespread, particularly using
solid-phase approaches. These techniques allow access
to sequences of up to 100 amino acids or 200
nucleotides, with the ability to install a wide variety of
functionalized monomers with precise positional con-
trol.22,51,52 Indeed, examples of oligonucleotide-material
conjugation rely almost exclusively on chemically
synthesized sequences. While the routine synthesis of
glycan sequences in an analogous manner remains a
pipedream, recent developments in glyco-chemistry are
beginning to make solid-phase oligosaccharide synthesis
a realistic prospect.53−55
4. CHEMICAL CONJUGATION
Chemical conjugation techniques are the most widely studied
and applied method for creating biomaterial−biomolecule
conjugates. This is partly due to the ease and generality with
which they can be undertaken, without the requirement for
specialist techniques or equipment. Here, we will split the
discussion by the key reactive handles or reaction mechanism
involved. Many of the bioconjugation strategies were ﬁrst
developed within the context of protein-small molecule
modiﬁcation. The reader is directed to a number of excellent
reviews on this topic, which forms the basis for much of the
work to be described in this section.36,48,56−58
4.1. Amine Reactive
Amine groups are widespread in native biomolecules, both on
the side chain of lysine residues and at the N-terminus of
polypeptides, and in amino-sugar glycan building blocks.
Similarly, both 3- and 5-amino modiﬁcation of oligonucleo-
tides is common. As such, amines provide perhaps the simplest
reactive handle for undertaking conjugation. This is reﬂected
by the extensive literature on their use, a wealth of detailed
protocols for their modiﬁcation, and the widespread
commercial availability of reagents and kits that allow
conjugation with minimal diﬃculty.59−61 However, the
common occurrence of amines which makes them so attractive
for achieving conjugation is also their most severe drawback:
modiﬁcation of amine residues is typically associated with low
site selectivity and the generation of heterogeneous product
isoforms, as discussed in section 3. For example, a typical
protein will possess numerous surface exposed lysine residues,
each of which will display similar reactivity. Eﬀorts to modify
amines therefore typically lead to biomaterial attachment at a
variety of sites, with a mixture of valencies. This poor site-
selectivity often leads to dramatic drops in bioactivity or
function. This is true even for short peptide substrates, where
competition between pendant lysines and the N-terminus can
occur. As a result, both the stoichiometry and position of
conjugation varies greatly during amine modiﬁcation and is
diﬃcult to control.36 Despite this major disadvantage, if only a
single amine motif is present in a peptide or glycan sequence,
or if the researcher is unconcerned about selectivity, amine
modiﬁcation may still be a viable method for conjugation. In a
particularly exciting recent development, Matos et al. have
Figure 3. EDC/NHS couplings are most commonly used to undertake amide couplings via a two-step process, ﬁrst activating the carboxylic acid at
pH 5, and subsequently undertaking conjugation at pH 8. However, the reaction is associated with side reactions which limit conjugation eﬃciency.
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demonstrated that careful tuning of reactivity and control of
stoichiometry can lead to single lysine modiﬁcation, even on
challenging protein substrates.62
4.1.1. Amide Formation. Amide formation is among the
most widely studied and used transformations in synthetic
chemistry. A vast range of coupling agents and carboxyl-
activating species therefore exist for undertaking such
reactions.63 When focusing on the aqueous conditions often
required for biomolecule conjugation the options are greatly
reduced. A small number of key methods have therefore
commonly been applied and will be discussed here.
The use of reactive N-hydroxysuccinimide (NHS) esters is
particularly widespread. While NHS-esters can be preformed,
often they are instead generated in situ through the use of N-
(3-(dimethylamino)propyl)-N-ethylcarbodiimide (EDC) cou-
pling chemistry and coupled directly to the species of
interest.60,64 Although formation of the activated NHS-ester
is favored under mildly acidic conditions (pH ∼5), subsequent
amide coupling is accelerated at higher pHs at which the amine
coupling partner is not protonated. One-step modiﬁcation at
an intermediate pH of ∼6.5 is possible, but this method is
characterized by low coupling eﬃciency.65 Conjugation is
therefore typically undertaken by ﬁrst forming the active NHS-
ester at pH 5, before raising the pH to ∼8 and adding the
amine coupling partner in a two-step procedure (Figure 3).60
Selectivity for amines is generally high. Although side reactions
with alcohols and thiols are known at basic pH, they occur at a
greatly reduced rate and are outcompeted in the presence of
amines. However, ester hydrolysis can be problematic in
aqueous conditions due to the high eﬀective concentration of
water.66
Despite the widespread use of EDC/NHS coupling for
biomolecule conjugation, a number of key limitations hinder
utility. In addition to the pH dependency described above, side
reactions are known to signiﬁcantly reduce reaction con-
jugation eﬃciency, including rearrangement of intermediate
EDC-esters to a stable and unreactive N-acylurea (Figure
3).67,68 Furthermore, the hydrophobicity of NHS-esters may
limit water solubility. To overcome this problem, the more
water-soluble derivative sulfo-NHS is often utilized as an
alternative, oﬀering a similar activation and coupling
proﬁle.67,69,70
EDC/NHS amide coupling chemistry has been widely used
in the biomaterial community despite these disadvantages, with
a vast body of literature highlighting the ease with which such
reactions can be applied to biomolecule conjugations.
However, the limitations of amine targeted ligations noted
above often make such reactions ill-suited to maximizing
biological eﬃcacy and construct performance.
It is important to note that peptide/protein conjugations are
poorly compatible with the functionalization of common
amine-containing scaﬀolds, such as collagen and chitosan, due
to competing cross-linking and intramolecular reactions.71,72 In
contrast, the oxidation of reducing oligo-saccharides to
generate terminal carboxylates enables glycan functionalization
of amino-scaﬀolds, albeit with concurrent loss of functionality
from the terminal monosaccharide.73,74 Similarly, the ease with
which terminal-amines can be introduced during oligonucleo-
tide synthesis has led to a number of reports on EDC/NHS-
mediated biomaterial-aptamer functionalization.75,76
A number of alternative coupling systems have been used for
biomaterial functionalization, though they continue to suﬀer
from the same limitations. These include the use of O-
nitrophenyl esters (which possess reduced stability in aqueous
conditions)77,78 or 1,1-carbonyldiimidazole (CDI) to form
amine-bridging carbamate linkages rather than amides.79,80
Hydrazines can also be used in place of amines during EDC/
NHS mediated couplings.68,81 Although not as widely available
or synthetically facile as the corresponding amine, the lower
pKa of hydrazines makes them less liable to protonation under
the mildly acidic conditions used for ester activation. As a
result, hydrazine-functionalized peptides can be coupled to
biomaterials in a single step at pH 5−6. In doing so, a degree
of site-selectivity can be achieved over lysine residues present.
This approach has been successfully implemented by Madl and
co-workers to conjugate reactive groups to alginate hydrogels,
enabling indirect functionalization with growth factors and
adhesion peptides.81
4.1.2. Reductive Amination. Amines can react reversibly
with aldehydes to form a transient imine moiety, with
accompanying elimination of water. This reaction takes place
in rapid equilibrium, with the unconjugated starting materials
being strongly favored in aqueous conditions due to the high
concentration of water. However, in a second step the unstable
imine can be irreversibly reduced to the corresponding amine
via treatment with sodium cyanoborohydride. This mild
reducing reagent enables the selective reduction of imines
even in the presence of unreacted aldehydes (Figure 4, reaction
ii).82 As a result, irreversible conjugation of a biomolecule can
gradually occur to a biomaterial of interest. However, rates of
reaction are often very sluggish due to the unfavorable
formation of the intermediate imine in aqueous condi-
tions.69,83−85 In contrast, stronger reducing agents such as
sodium borohydride are also able to reduce aldehydes.
Figure 4. Imine formation is the rate-limiting step during reductive amination. Sodium borohydride is able to reduce the aldehydes which dominate
and therefore fails to generate the desired conjugate. In contrast, sodium cyanoborohydride selectively reduces imines, leading to the formation of
stable amine-conjugates.
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Conjugation is therefore ineﬀective with alcohol formation
dominating (Figure 4, reaction i).
This two-step reductive amination process can also be
utilized for the modiﬁcation of ketones. However, such
reactions are rarely used for biomaterial conjugation due to
even slower reaction kinetics and the ease with which
aldehydes can be introduced into polysaccharide based
scaﬀolds through the oxidation of primary alcohols.86
Reductive amination has therefore been primarily used for
the modiﬁcation of sodium periodate-treated alginate and
chitosan scaﬀolds, though care must be taken not to disrupt
the physical and chemical properties of the core material
through overoxidation.86 The order of reactivity can also be
reversed for the attachment of reducing sugars, by exploiting
the terminal aldehyde/ketone generated in the open-chain
form. This strategy has been commonly exploited to mimic the
glucosylation and galactosylation patterns of native collagen in
ECM, via reductive amination of maltose87 and lactose88−90
respectively, as well as more recently by Sgamboto et al. to
install sialoside epitopes able to drive stem cell fate.91
4.1.3. N-Terminal Modiﬁcation. Although amine mod-
iﬁcations typically proceed with low site-selectivity, the N-
terminus of polypeptides has subtly altered reactivity when
compared to the side-chains of lysine residues and oﬀers
opportunities for selective conjugation. This unique reactivity
results from the slightly lowered pKa of the N-terminal amine,
and the structural environment imparted by the adjacent amide
group of the peptide backbone.44 A number of methods for
achieving site-selective N-terminal modiﬁcation have been
reported in the context of protein−small molecule conjuga-
tion.92−94 However, to the best of our knowledge, such
methods have only been utilized on a single occasion to
directly conjugate a polypeptide to a biomaterial scaﬀold. Lee
et al. recently demonstrated that 2-pyridinecarboxaldehyde
modiﬁed acrylamide hydrogels could react speciﬁcally with the
N-terminus of ECM proteins, forming a cyclic imidazolidinone
product with the adjacent amide bond and enabling the
orientated display of these key bioinstructive motifs (Figure
5).95 Although imine formation with lysine residues is also
possible, this reversible reaction is in thermodynamic
equilibrium and the added stability aﬀorded by formation of
the imidazolidinone drives N-terminal speciﬁcity.
This method is highly attractive as a means to form
biomaterial-conjugates, due to its ability to site-speciﬁcally
conjugate any peptide or protein that possesses a solvent
exposed free N-terminus. It is important to note that eﬀective
conjugation relies on an equilibrium-driven process, albeit one
that favors product formation. The stability of the resultant
construct is thus a vital consideration and merits further
investigation.93 If this potential shortcoming can be overcome,
such reactions will be applicable to a wide range of
commercially available, recombinant, or synthetic substrates
and can be expected to ﬁnd increasing utility in the near future.
However, substrate scope may be partially limited by the
extensive occurrence of natural N-terminal post-translational
modiﬁcations in eukaryotic proteins.96
Although the C-termini of proteins also have the potential
for unique reactivity, the targeting of such groups remains
challenging. A recent report of selective C-terminal decarbox-
ylation by the MacMillan group highlights the possibility of
targeting such residues in the future.97 However, the poor
functional group tolerance of this reaction is currently limiting.
Further developments, able to oﬀer exquisite chemo-selectivity
over other carboxylic acids with only subtly shifted reactivity,
would represent a major advance.
4.2. Thiol Reactive
The thiol group of cysteine is the most nucleophilic functional
group found among the 20 proteinogenic amino acids.
Figure 5. N-terminal speciﬁc conjugation can be used to functionalize 2-pyridinecarboxaldheyde (2PCA) hydrogels with native ECM proteins.
Increased cell spreading is observed with increased scaﬀold functionalization with (a) collagen, (b) ﬁbronectin, and (c) laminin. Adapted from ref
95. Copyright 2016 with permission from Elsevier.
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Through careful control of pH, selective modiﬁcation over
other nucleophilic residues such as lysine can be readily
achieved.49 The redox sensitivity of thiols further diversiﬁes the
chemical modiﬁcations they may undergo. When coupled with
the low natural occurrence of cysteine residues (<2%, typically
lower among surface exposed residues) and the ease with
which they can be engineered into recombinant proteins, thiol
groups emerge as particularly attractive targets for undertaking
site-selective polypeptide conjugation (see section 10 for a
discussion on cysteine introduction).98 A wide-range of
powerful modiﬁcation strategies have been developed for
tethering thiol-containing peptides and proteins to biomaterial
substrates, and such methods are among the most widely used
in the ﬁeld of tissue engineering.99 Thiol modiﬁcation of
oligonucleotides has also been commonly used to enable
derivatization, though the ease with which alternative reactive
handles with enhanced chemical orthogonality can be installed
has limited use for biomaterial-conjugation.
Despite the advantages noted above, the modiﬁcation of
thiols is not without its drawbacks. While it may at ﬁrst seem
counterintuitive, the rarity of cysteine in native proteins
highlights their vital importance in controlling activity. Many
cysteine residues are therefore found within enzymatic active
sites or else form key structural disulﬁde bridges.100 As a result,
often wild-type cysteine residues are either not accessible for
modiﬁcation or at best can be altered only at the drawback of
greatly decreased protein activity. Although additional thiols
can be introduced onto the surface of proteins through the
modiﬁcation of lysine residues with Traut’s reagent, the
resultant conjugates suﬀer from the same lack of amine-
selectivity described above and thus possess low strategic
value.60 Even within short synthetic peptides, cysteine residues
are often key to activity, while disulﬁde bridges are commonly
used to induce cyclization and boost biological eﬃcacy.101 This
propensity of cysteine residues to oxidation can also prove
problematic when precise modiﬁcation stoichiometry is
required, necessitating prior disulﬁde reduction before
conjugation is undertaken.49,102
4.2.1. Michael Addition. The conjugate addition of thiols
to α,β-unsaturated carbonyls, also known as Michael addition,
is perhaps the most widely used method to form polypeptide
conjugates in the ﬁelds of tissue engineering, functional
materials, and protein modiﬁcation. A number of detailed
reviews focusing solely on this reaction class have been
published, and the reader is directed to these for a
comprehensive overview of reaction mechanism, kinetics,
reagent choice, and applications across a broad range of
topics.103,104 Herein, we will focus on the key factors that
determine conjugation eﬃciency in the context of biomate-
rial−biomolecule ligation.
The Michael addition of thiol groups proceeds in a highly
speciﬁc manner under mild conditions, with almost quantita-
tive conversion even in dilute solutions. Furthermore, the
reactions are largely insensitive to the presence of water,
oxygen, and salts, greatly facilitating their implementation in
tissue engineering and biomaterial applications.105
In general, reaction rates and conjugation eﬃciencies are
primarily controlled by three factors:
(i) The pKa of the thiol. The thiolate anion is the active
nucleophile during Michael addition, and the propensity of the
thiol to undergo deprotonation therefore determines thiolate
concentration and thus reaction rates. For example, the lower
pKa of aromatic thiols, when compared to their aliphatic
counterparts, leads to a higher rate of reaction rate a weak base
is used to catalyze the reaction (see below).103,106 As a result,
local structure can signiﬁcantly alter conjugation eﬃciency,
particularly for polypeptide substrates. The pKa and reactivity
of cysteine containing peptides can be altered signiﬁcantly
through rational choice of surrounding amino acids. Speciﬁ-
cally, the presence of positively charged amino acids, such as
lysine and arginine, acts to lower the thiol pKa and thus
enhance reactivity. In contrast, aspartic or glutamic acid
residues retard reaction.107 Careful peptide design is therefore
a key consideration when designing a biomaterial conjugation
strategy.
(ii) The electrophilicity of the Michael-acceptor. In general,
as the Michael-acceptor becomes more electron deﬁcient it
becomes more activated toward nucleophilic attack, and thus
reaction rates increase. Within the most widely utilized
acceptors in the biomaterial ﬁeld, a trend of reactivity can be
generalized as maleimides > vinyl sulfones > acrylates >
acrylamides > methacrylates (Figure 6).103 Each of these
acceptor classes will be discussed in turn below.
(iii) The choice of catalyst. Michael additions can be
accelerated by either basic or nucleophilic catalysis (although
both act by increasing the concentration of the active
thiolate108,109). During basic catalysis, the pKa of the thiol
becomes less signiﬁcant for reaction rate with increasing base
strength. As biomolecule conjugations are typically undertaken
in buﬀered aqueous solution, it can be summarized that with
increasing buﬀer pH reaction rates will also increase. However,
it is important to note that above pH 8 competing amine
Michael addition and thiol oxidation reactions may become
signiﬁcant, leading to a drop in conjugation eﬃciency and
Figure 6. The rate of thiol Michael addition is dependent on the
electrophilicity of the acceptor. The more electron-deﬁcient an alkene,
the more susceptible it is to nucleophilic attack.
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speciﬁcity which can be highly detrimental to the end
application.110,111
These complementary factors must all be carefully
considered when preparing a biomolecule−material conjugate,
with applicability often determined by the end function of the
scaﬀold.112,113 For example, a rapid rate of reaction may be
required when utilizing a peptide to induce hydrogelation, to
minimize gel defects and ensure rapid gelation at the site of
administration, or for the eﬃcient attachment of proteins or
oligonucleotides present at dilute concentrations.114−116
However, if reactivity is too high, oﬀ-target conjugation
(particularly with amines) or inadequate mixing of reaction
components may occur, which in turn leads to heterogeneous
devices with poor performance.117,118
4.2.1.1. Maleimides. Maleimides are the most widely used
Michael-acceptors within the biomaterial community. The high
reactivity of the maleimide group originates from a
combination of the 2 electrophilic carbonyl groups, arranged
in a reactive cis conformation, and the high bond strain
induced by the unsaturated 5-membered ring.105 As a result,
thiol conjugation occurs rapidly even at neutral pH. The
kinetics of the thiol-maleimide reaction are particularly useful
for undertaking conjugation at low concentrations or when
requiring extremely high eﬃciencies due to the value of the
biomolecule substrate. Maleimides are therefore often seen as
superior to alternative Michael-acceptors in many applica-
tions.115 The widespread use of maleimides is further enhanced
by the ease with which they can be introduced into a wide
range of scaﬀold materials, through the modiﬁcation of amines
with the difunctional reagent succinimidyl 4-(N-
maleimidomethyl)cyclohexane-1-carboxylate, more commonly
referred to by its abbreviation SMCC. This reagent has been
widely used to ﬁrst introduce a maleimide reactive handle on a
biomaterial of choice and then to enable the attachment of
both peptides119−123 and growth factors124−128 to produce
bioactive scaﬀolds. Importantly, although selectivity is high at
neutral pH (the thiol-maleimide reaction rate is >1000 times
faster than reaction with amines), because maleimides are so
reactive the rates of side reactions are not inconsequential. At
high amine or low thiol concentrations the contribution of
undesired conjugations can become an important consider-
ation. Furthermore, selectivity is lost under weakly basic
conditions, and careful control of pH is therefore essential to
prevent side-reaction at lysine residues.129
Although maleimides are generally perceived to form stable
conjugates, following a simple Michael addition mechanism,
many recent reports have highlighted the reversibility of thiol
conjugation via a retro-Michael reaction (Figure 7).131−133 In
the absence of exogenous thiols, the eﬀect of reversibility is
negligible, with the biomaterial-conjugate being rapidly
reformed. However, in many biological environments an
excess of thiols exist, for example on cell surface proteins, or
in the form of small molecule metabolites such as
glutathione.134,135 Thiol-exchange can then result, through
the equilibration of forward- and retro-Michael additions,
leading to a gradual loss of conjugation and a drop in device
performance. This situation is complicated further by the
competitive formation of stable conjugates by ring-opening
hydrolysis of maleimide−thiol adducts under basic conditions.
Recent literature has exploited this side reaction and
highlighted the ability of adjacent amines,136,137 ortho-amino
aromatics,138 and electron withdrawing phenyl groups139 to
accelerate the rate of hydrolysis, minimizing the eﬀects of
retro-Michael addition and allowing the production of stable
bioconjugates. Kalia et al. have further demonstrated that
exocyclic maleimides are less prone to retro-addition.140
Exploiting these recent developments for biomaterial function-
alization may thus overcome some of the limitations of current
maleimide modiﬁcation strategies.
4.2.1.2. Vinyl Sulfones. The Michael addition of thiols to
activated vinyl sulfones to form biomolecule−material
conjugates was ﬁrst reported by Lutolf and Hubbell (Figure
2).111 In a series of papers, they demonstrated that cysteine
capped peptides could cross-link vinyl-sulfone functionalized
multiarm PEGs to form protease responsive hydrogels,
enabling cell invasion during tissue growth.111,141−143 The
vinyl sulfone double bond is less electrophilic than analogous
maleimide substrates. Michael additions therefore occur at a
slower rate, yet still proceed rapidly to high conjugation
eﬃciencies suﬃcient for most applications. In contrast to
maleimide adducts, the resultant thioether bond is resistant to
hydrolysis and is therefore particularly attractive when
Figure 7. Maleimide adducts can undergo retro-Michael addition and
thiol-exchange in the presence of exogenous thiols. (a) Decrease in
storage modulus of maleimide−thiol cross-linked hydrogels following
incubation with diﬀerent concentrations of glutathione (GSH); (b)
increased hydrogel swelling as a result of decreased cross-linking
density. Adapted from ref 130 with permission of The Royal Society
of Chemistry.
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construct stability is key to device performance. Although
cross-reactivity with amines and alcohols has been reported in
the absence of suitable thiol nucleophiles, these side reactions
are signiﬁcantly slower than those observed with maleimides.
Selectivity is therefore generally very high, particularly with
careful control over reaction pH.144−146 Vinyl-sulfone
additions have therefore been widely utilized for the
conjugation of peptide147−150 and protein substrates144,151 to
a variety of biomaterial scaﬀolds.
4.2.1.3. Acrylates, Acrylamides, and Methacrylates.
Acrylates and methacrylates are versatile reactive handles
which can be used to ligate biomolecules via a number of
diﬀerent reaction modes. As well as their propensity to
undergo Michael addition, as described here, they may also
undergo radical mediated polymerization, cross-linking, and
cross-conjugation as discussed in sections 6 and 7.1. This
diverse reactivity can in itself be problematic. Acrylate
substrates in particular must be carefully stored cold and
away from light to prevent unwanted polymerization.152
Acrylates have been widely used as Michael acceptors for
conjugation due to the ease with which they can be introduced
into both material and biomolecule coupling part-
ners.151,153−158 Although reaction rates are inferior to
maleimides and vinyl sulfones they are fast enough for many
applications, making acrylates an eﬃcient, facile, and
reasonably fast handle for undertaking conjugation. Indeed,
the reactivity of acrylates remains high enough for side-
reactions with amines to occur when reaction conditions are
not carefully controlled.159,160 The lower electrophilicity of
methacrylates provides higher thiol selectivity, though at the
cost of drastically reduced reaction rates and eﬃ-
ciency.107,160,161
For both acrylate and methacrylate handles, the presence of
a hydrolytically labile ester linkage is an important and often
overlooked factor. Although susceptibility to gradual cleavage
may be advantageous in certain circumstances, often the loss of
conjugated biomolecule is highly detrimental to device
performance. While methacrylate hydrolysis is slower, cleavage
can still occur quickly under physiological conditions.151 As an
alternative, amide-linked acrylamides provide improved
stability for biomaterial conjugation. However, this comes at
the cost of a dramatic reduction in reactivity, with the reduced
electrophilicity imparted by the amide bond leading to a
further drop in reaction kinetics.153
4.2.1.4. Thiol−yne. The most common examples of thiol-
Michael additions occur at electron-deﬁcient alkenes, so-called
“thiol−ene” reactions. Although less commonly exploited,
“thiol−yne” additions to activated alkynes, such as propiolic
acid esters, have also been reported for biomaterial
functionalization. Under weakly basic conditions a mixture of
alkene isomers are generated following addition. Unlike the
radical thiol−yne reactions to be discussed in section 7.3, these
adducts do not typically undergo further conjugation and
therefore form a monoaddition product.162−164 The nucleo-
philic thiol−yne reaction has been shown to be a cell-
compatible method for hydrogel formation and peptide
functionalization, although a degree of cross-reactivity with
amines may still hinder complete selectivity.163
4.2.2. Disulﬁde Formation. Thiols undergo spontaneous
oxidation to form disulﬁde bonds under ambient conditions.
This redox sensitivity is widely exploited in nature to induce
and maintain protein and peptide stability. Although disulﬁde
formation can be promoted by added oxidant and utilized as a
method for polypeptide conjugation,128,165,166 spontaneous
oxidation is typically slow and proceeds with low selectivity
due to the formation of either mixed disulﬁdes or
homodimers.36,49 The use of disulﬁde exchange reactions is
therefore favored for introducing peptides or proteins of
interest. The most commonly used reagents in tissue
engineering are based upon reactive pyridylthio-disulﬁdes,
which undergo rapid thiol-exchange to release the poorly
nucleophilic and spectroscopically active 2-mercaptopyri-
dine.167−170 The resultant conjugation products are largely
stable under ambient conditions. However, due to the
reversible nature of disulﬁde bond formation, cleavage can be
controlled with temporal precision by the addition of reducing
agents such as dithiothreitol (DTT) or glutathione.130,170,171
While this sensitivity to thiol exchange may be advantageous
for certain applications, it can also prove problematic when
irreversible modiﬁcation is desired, particularly in vivo where
native thiols can lower stability within the extracellular
environment.109
4.2.3. Other Thiol Modiﬁcations. The unique nucleo-
philicity of thiols can be exploited for selective reaction with a
number of alternative electrophiles, which, while less
commonly used for biomaterial conjugation than Michael
acceptors, still allow eﬃcient and selective biomolecule
attachment to be achieved. One such group are α-
halocarbonyls, with iodoacetamide based reagents ﬁnding
particular utility.167,172 Higher thiol selectivity can be achieved
using less electrophilic bromo and even chloro derivatives,
though reactivity is also drastically reduced.49 More recently,
methylsulfonyl heteroaromatic derivatives have emerged as
promising reagents for thiol-speciﬁc conjugation. These
reagents rely on nucleophilic aromatic substitution to
eﬃciently and selectively introduce stable thiol modiﬁcations
under ambient conditions.173 The group of del Campo have
shown that these reagents can eﬀectively functionalize
hydrogels with both peptide and protein substrates.174,175
There is much interest in the identiﬁcation of alternative
thiol-reactive handles, such as disulﬁde-bridging pyridazine-
diones,176,177 carbonylacrylic reagents,178 and cyclopropenyl
ketones179. These reactive handles possess fast reaction
kinetics, yet overcome the instability of maleimide derivatives.
Though currently limited to the formation of small molecule
conjugates, such developments are at the cutting edge of
bioconjugation strategies. It is critical that further inves-
tigations are undertaken to comprehensively determine the
thiol-selectivity of these motifs under diverse and challenging
conditions, to enable future advances in biomaterial function-
alization.
In a ﬁnal example of thiol-reactive conjugation, native
chemical ligation (NCL) can be utilized to attach peptides and
proteins to biomaterial scaﬀolds via peptide bond formation.
NCL relies on the reversibility of thioester formation, enabling
the exchange of a reactive thioester present on one reacting
species, with an N-terminal cysteine on the other.180−182 Due
to the favorable steric arrangement of the resultant complex, a
chemo- and regioselective S,N-acyl shift can occur, leading to
peptide bond formation between the two reaction compo-
nents. The application of NCL in the ﬁeld of biomaterial
conjugation is limited by diﬃculties in producing the thioester
reaction partner, and the slow reaction kinetics which
necessitate extended conjugation periods.183 However, NCL
has been successfully applied to the formation of peptide cross-
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linked hydrogels, via the reaction of cysteine end-caps with
thioester functionalized hydrogel building blocks.183−185
4.3. Cycloaddition Reactions
The past 20 years has seen an explosion in the popularity of
cycloaddition reactions for undertaking selective, fast, and
often mild biomolecule−material conjugation. Although many
cycloadditions were ﬁrst identiﬁed in the middle part of the
20th century, it is only more recently that a number of key
developments have enabled their routine use in tissue
engineering. During cycloaddition, two or more unsaturated
molecules are brought together to form a cyclic product with a
reduction in the degree of unsaturation (Figure 8). The
reaction partners required are typically absent from natural
systems, and so the use of cycloadditions for conjugation
requires the introduction of unnatural functionality within the
biomolecule coupling partner. This requirement may limit
application and ease of implementation, though, as described
in section 10, a wide range of methods for installing the
required functional groups are now available and are routinely
utilized in molecular biology and tissue engineering.
4.3.1. Copper-Catalyzed Azide−Alkyne Cycloaddi-
tions (CuAAC). The (3 + 2) cycloaddition between an
azide and alkyne proceeds spontaneously at high temperatures
(>90 °C), producing a mixture of two triazole isomers.186
However, these high temperatures are prohibitive for most
applications, and the thermally induced reaction has found
little use. A major breakthrough was achieved in 2002,
independently by the groups of Sharpless187 and Meldal188,
with the demonstration that copper(I) catalysis could
dramatically promote and accelerate triazole formation (in
exclusively the 1,4-conformation). This reaction was found to
proceed at room temperature, even in ambient, oxygenated,
and aqueous environments. These mild reaction conditions,
together with the relative inertness of azides and alkynes and
their absence from biological systems, has led to the copper-
catalyzed azide−alkyne cycloaddition (CuAAC, often referred
to as the “copper-click” reaction, Figure 8a) ﬁnding widespread
use across the biological, chemical, and material scien-
ces.189−195
Following on from the early work of the Hilborn196 and
Hawker197 groups, Polizzotti et al. reported the formation of
peptide−material conjugates by CuAAC, using alkyne-capped
peptides to form hydrogels with azide-functionalized PEG
(Figure 2).198 Since this early work, the CuAAC has been
widely used to functionalize scaﬀolds with alkyne and azide
functionalized peptides and carbohydrates, in part due to the
ease with which the amino acids azidolysine and homopro-
pargylglycine can be introduced by solid-phase peptide
synthesis.193,199−203
To achieve biomaterial conjugation via CuAAC, the required
copper(I) catalyst can either be added directly, or generated in
situ by reduction of an initial copper(II) complex, most
commonly using ascorbic acid. The addition of a reducing
agent further reduces the sensitivity of the CuAAC ligation to
oxygen, which may otherwise detrimentally oxidize copper(I)
to an inactive copper(II) species. Although no additional
ligand is necessary for triazole formation, the addition of
tertiary amine based ligands has been shown to stabilize the
copper(I) catalytic complex and to signiﬁcantly improve
reaction kinetics and eﬃciency. A wide range of ligand and
catalyst combinations have been reported for undertaking
CuAAC reactions and reviewed elsewhere.204 Importantly, the
choice of a speciﬁc system is often dependent on the particular
application in mind, and the interaction of the copper catalyst
with the core scaﬀold structure, the ease of copper removal
following conjugation, the concentration of the biomolecule
partner, and the cost of catalyst−ligand systems must all be
considered.
Azide and alkynes are generally stable under standard
conditions, though a couple of important considerations
should be taken into account when designing a CuAAC
conjugation strategy. The alkyne reactive partner in particular
is susceptible to side reactions. Perhaps most signiﬁcantly,
activated alkynes such as propiolic esters can react with thiols
via thiol−yne addition, as described in section 4.2.1.4, making
this substrate class poorly compatible with selective mod-
iﬁcation.205,206 Similarly, propargyl esters and carbamates
Figure 8. Key advantages and limitations of cycloaddition reactions
used for biomolecule-material conjugation. (a) Copper-catalyzed
azide−alkyne cycloaddition (CuAAC); (b) strain-promoted azide−
alkyne cycloaddition (SPAAC); (c) inverse-electron demand Diels−
Alder reaction (IEDDA); and (d) furan-maleimide Diels−Alder
reaction.
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should be avoided, due to their susceptibility to copper-
catalyzed cleavage.205
Despite the prevalence of CuAAC reactions in the
biomedical ﬁeld, the need for copper catalysis comes with
severe drawbacks. The most prominent lies in the toxicity of
residual metal, which is known to bind nonspeciﬁcally to
peptide and protein substrates and is often diﬃcult to
remove.207−210 Furthermore, it has been shown that copper
may disrupt peptide and protein structure, leading to a loss of
function following conjugation.211 The eﬀects of copper are
even more deleterious for oligonucleotide sequences, with the
copper-induced generation of reactive oxygen species (ROS)
resulting in base modiﬁcations and backbone scission.158
These problems are exacerbated by the need for high catalyst
loadings to maintain conjugation eﬃciency, as a result of the
high aﬃnity of copper for both the triazole reaction product
and many biologically relevant functional groups, eﬀectively
sequestering the active catalyst from the conjugation
mixture.200 These limitations can be partially mitigated by
ligands able to strongly stabilize the active copper(I) catalyst or
chelate azides to enhance reaction rates,212−214 though copper
induced damage to biomolecules is still problematic.209
Interestingly, the generation of active copper(I) via photo-
initiated reduction of a copper(II) precursor has recently been
reported by Adzima et al.215 This allows the induction of
CuAAC reactions with spatial and temporal control, with
patterning of features as small as 5 μm being reported. This
resolution is dictated by the speed at which the catalyst is
deactivated by oxygen and is increased by the aforementioned
aﬃnity of the copper for the triazole reaction product which
signiﬁcantly slows catalyst diﬀusion.215,216 Although the
photoinitiated CuAAC has not yet been exploited for
biomolecule conjugation, these early reports of spatial hydrogel
patterning oﬀer intriguing possibilities to do so in the near
future.
4.3.2. Strain-Promoted Azide−Alkyne Cycloadditions
(SPAAC). In 2004 the Bertozzi group published a seminal
report on the use of strain, rather than metal catalysis, to
promote the azide−alkyne cycloaddition (SPAAC, or often the
“copper-free click reaction”, Figure 8b).217 Building upon the
work of Wittig and Krebs in the 1960s,218 they showed that
highly strained cyclooctynes react readily with azides to form
triazoles under physiological conditions, without the need for
any added catalyst. Without the need for a transition metal
species, the azide−alkyne cycloaddition is essentially nontoxic,
with the high bioorthogonality of the reaction allowing it be
applied to live cells and even inside animals.219−223
Since the original reports on SPAAC using simple
cyclooctynes, a series of increasingly strained, and thus
increasingly reactive alkynes have been reported, with
corresponding increases in reaction rates and eﬃciencies
(from an original reaction rate k ≈ 0.002 M−1 s−1, up to k ≈ 1
M−1 s−1 in the most recent incarnations).224 These moderate
rates may prove high enough for eﬃcient conjugation under
standard conditions. However, even the most reactive
cyclooctyne substrates may still result in low conjugation
eﬃciencies at low concentrations of, for example, a biologically
active protein.225 Furthermore, increased rates of reaction
come at the cost of decreased stability and therefore increased
chance of cross-reactivity. In particular, cyclooctynes have been
shown to react at non-negligible levels with thiol groups,
reducing the bioorthogonality of SPAAC reactions in the
presence of cysteine containing proteins and peptides.221,226,227
The low water-solubility of the cyclooctyne group may also
prove problematic. In addition to the problems this creates in
solubilizing the conjugation-partners and the decreased
availability of the reactive handle, increased lipophilicity may
also lead to increased nonspeciﬁc biomaterial binding and a
loss of strategic value to pursuing site-selective conjuga-
tion.224,228−230 Finally, the accessibility and availability of
SPAAC reagents must also be carefully considered. The
laborious multistep synthetic routes required for cyclooctyne
construction often rely on specialist techniques, which in turn
prevent their widespread production in biomedical and tissue
engineering laboratories.224,231 Although suitably function-
alized derivatives are becoming increasingly commercially
available, high costs partially limit their further application.
In spite of these disadvantages, the low toxicity and high
selectivity under controlled conditions provided by SPAAC
have made it a popular emerging method for conjugation.
DeForest and Anseth were the ﬁrst to demonstrate the use of
SPAAC to cross-link PEG-azide based hydrogels, using
cyclooctyne-functionalized, MMP-cleavable peptides (Figure
2).232 A series of papers have subsequently developed this
experimental setup,233−235 with biomaterial functionalization
in the presence of cells of particular note. In contrast to the
analogous CuAAC modiﬁcation strategy, little to no cellular
toxicity has been reported in a variety of systems, even at high
reagent concentrations.230,234,236,237 This cytocompatibility of
SPAAC reactions is particularly attractive, as is the lack of ROS
generation, enabling the eﬃcient functionalization and cross-
linking of hydrogels with complementary DNA strands.238
In addition to the use of SPAAC for peptide conjugation, a
number of prominent reports have used SPAAC to conjugate
protein substrates to cyclooctyne functionalized biomaterials.
Key to these reports is the introduction of an unnatural azide
motif into the protein coupling partner. This has been achieved
via a number of routes, including maleimide functionalization
of native cysteines present in bone morphogenetic protein-2
(BMP-2),239 via enzyme-mediated N-terminal modiﬁcation of
IFN-γ,240 or via codon reassignment with the unnatural amino
acid 4-azidophenylalanine in a number of protein substrates,225
as discussed in section 10.
As an alternative to strain-promotion, the Francis group has
recently reported that supramolecular host−guest interactions
can also be used to promote azide−alkyne cycloaddition.241 By
bringing the two reactive partners into close proximity within
the cavity of a cucurbit[6]uril host, eﬃcient cycloaddition
could be achieved on the surface of proteins. Although
proximal tertiary amines were necessary on both the azide and
alkyne coupling partner to promote formation of the necessary
host−guest complex, such reactions oﬀer the potential to
overcome the limitations of both CuAAC and SPAAC noted
above, and are of merit for further investigation in the ﬁeld of
biomaterial functionalization.
4.3.3. Inverse-Electron Demand Diels−Alder Reac-
tions (IEDDA). In recent years, the inverse-electron demand
Diels−Alder (IEDDA) reaction between 1,2,4,5-tetrazines and
strained alkenes or alkynes has garnered signiﬁcant interest
(Figure 8c). IEDDA reactions oﬀer high bioorthogonality and
compatibility, along with very fast reaction rates.242 Unlike
standard Diels−Alder reactions, which often require elevated
temperatures and utilize reactive groups which are susceptible
to nucleophilic attack, IEDDA reactions proceed sponta-
neously to irreversibly release nitrogen gas and form a stable
dihydropyridazine product. Through suitable choice of
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reaction partners, kinetics can be tuned over 10 orders of
magnitude up to impressive rates of 105 M−1 s−1 (the reader is
directed to an excellent recent review by Mayer and Lang for a
detailed description of the factors inﬂuencing IEDDA
reactions).243
Although tetrazine stability decreases with increasing
reactivity, a wide range of suitable derivatives for undertaking
biomolecule conjugation have been reported. For example, 4-
hydro-tetrazines have been shown to degrade rapidly in
buﬀered solution over a matter of hours, limiting their utility
for reproducible conjugation. However, 4-methyl-derivatiza-
tion greatly improves stability, while maintaining suﬃcient
reactivity for eﬀective conjugation.228 Similarly, triazines have
recently been shown to provide a compromise between high
reactivity and eﬀective conjugation.244
A variety of strained alkenes/alkynes are also suitable for
IEDDA reactions. The most popular belong to a series of
increasingly strained (and thus reactive) trans-cyclooctenes
ﬁrst introduced by the group of Fox.245−248 Although
cyclooctenes oﬀer the highest reactivity, as for the cyclooctynes
utilized for SPAAC their synthetic and commercial accessibility
partially hinders their application. Furthermore, their ability to
undergo isomerization to the signiﬁcantly less reactive cis-
alkene in the presence of thiols may prove limiting.249 In
contrast, suitably functionalized norbornene derivatives are
widely available and thus provide a facile handle for
undertaking IEDDA reactions. Although reaction rates are
greatly reduced (typically 1−10 M−1 s−1),243 they remain high
enough to undertake conjugation in most cases and compare
favorably with those possible through CuAAC and SPAAC
ligations.250−252 Recently developed spirohexene reactive
handles oﬀer a potential alternative, combining suﬃcient
stability with fast reaction rates.253
IEDDA reactions have been implemented in a number of
instances for the formation of functional materi-
als.162,243,254−257 However, despite its attractive features the
use of IEDDA for biofunctionalization has to date been
limited. In the most prominent example, Alge et al. used
norbornene-functionalized peptides to induce hydrogelation of
tetrazine-capped PEGs (Figure 2).258 In this case, the reactivity
of the norbornene group was suﬃciently high to allow rapid
gelation, while still enabling thorough mixing and the
minimization of gel defects. Furthermore, residual norbornene
residues could be used for subsequent photoinduced thiol−ene
reactions (see section 7.2), allowing further material
derivatization and the incorporation of additional bioinstruc-
tive peptides and proteins. Importantly, Truong et al. have
noted that the generation of nitrogen as a reaction side-
product may be potentially detrimental to the use of IEDDA
cycloadditions for hydrogel formation.162 Particularly in dense
networks, this gas can be trapped, forming bubbles which act as
gel defects and disrupting the desired homogeneity of ideal
gels.
4.3.4. Furan-Maleimide Diels−Alder Reactions. The
hetero-Diels−Alder cycloaddition of maleimides and furans
proceeds with good chemo-selectivity and is greatly accelerated
in aqueous conditions, lending itself to the formation of
biomaterial conjugates.259−261 Although conjugation is possi-
ble at neutral pH, reaction rates are accelerated under slightly
acidic conditions. Furan-maleimide additions have predom-
inantly found use as a method to cross-link synthetic or natural
polymers for the construction of core biomaterial scaﬀolds
(Figure 8d).172,262−265 Examples of such reactions being used
for biomolecule conjugation are rare,266,267 in part due to the
rapid and well-established reaction of maleimides with thiols,
as described above in section 4.2.1. Diels−Alder conjugations
are therefore not suitable for functionalization in the presence
of thiolated biomolecules or materials.
The desired Diels−Alder process is in equilibrium with the
corresponding reverse retro-Diels−Alder reaction, regenerating
the starting maleimide and furan. High temperatures are
typically required in order to shift the equilibrium in favor of
the starting materials; however, at 37 °C the contribution of
the retro-reaction is non-negligible. While in many cases this
may be detrimental to the ﬁnal outcome, it can also be
exploited for applications in which controlled release is desired.
Koehler et al. have described the coupling of furan-function-
alized RGDS peptides to maleimide-functionalized PEG-
hydrogels.268 By controlling the ratio of free maleimides in
the system, which act to eﬀectively trap the furan-peptide by
promoting the forward Diels−Alder reaction, the rate of
peptide release could be tuned. Alternatively, the eﬀects of the
retro-Diels−Alder reaction can be mitigated by utilizing
difunctional peptides for cross-linking.269 In such scenarios,
although retro-reaction may still occur, the peptide is not
released as it remains tethered at the other end, and the
forward Diels−Alder reaction is allowed to proceed once again
(Figure 9). It should be noted that the coupling of furans and
maleimides can generate two stereoisomers, and thus a mixture
of endo and exo products exists at ratios dependent on the
precise structures and coupling conditions.260 Although the
impact of this is rarely discussed in the context of biomaterial
conjugation, it is known that endo isomers undergo retro-
Diels−Alder reactions at a lower temperature than the
analogous exo structure.270 In systems where reversibility is
desired, this isomer-dependency is therefore an important
design consideration.
4.4. Oxime and Hydrazone Formation
Aldehydes and ketones are absent from proteinogenic amino
acids and typically only found at the open-form termini of
reducing sugars. When combined with their propensity to react
with a wide range of nucleophiles, this makes them attractive
handles for undertaking polypeptide and glycan conjugation.
As already described in section 4.1.2, aldehydes undergo
reversible reactions with amines to form transient imines,
which can then be trapped by reductive amination. However,
under aqueous conditions hydrolysis by water dominates and
the imine intermediate is highly disfavored and unstable. In
contrast, the increased nucleophilicity of hydrazines and
hydroxylamines allows them to form hydrazone and oxime
bonds respectively, with greatly increased stability (Figure 10).
These reactions are commonly used as a means to modify
biomolecule substrates across the biological and physical
sciences.271
Hydrazines react to form hydrazone linkages readily under
mildly acidic or neutral conditions, with elimination of water.
Although hydrazone bonds are more stable than the analogous
imine, with an equilibrium favoring product formation, they
remain prone to hydrolysis and their formation is thus
reversible.272 While this may be damaging if conjugate stability
is required, the dynamic nature of the hydrazone bond can also
be exploited to create self-healing or degradable materials
(Figure 11).69,273−275 Indeed, it has been shown that in vitro
cytocompatibility and cell growth can be enhanced within
structurally dynamic biomaterial scaﬀolds. The beneﬁcial
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plasticity imparted by these structures is believed to allow cells
to manipulate and model their local environment.274
The rate of hydrolysis is closely linked to hydrazone
structure, and in particular basicity. Both bond formation and
hydrolysis are promoted under mildly acidic conditions,
following protonation of the imine nitrogen. Oommen et al.
have demonstrated that hydrazino-ureas allow a greater than
15× increase in stability to be achieved under mildly acidic
conditions, and with negligible hydrolysis at neutral pH as a
result of the electron withdrawing urea motif.276 Similarly,
equilibrium can be shifted strongly toward product formation,
through the use of aliphatic rather than aromatic hydra-
zines.274,277 The rate of hydrolysis can therefore be tuned over
several orders of magnitude, from minutes to months,
depending on the desired application.272 The stable attach-
ment of peptides and DNA to biomaterials via hydrazone
formation can be achieved via difunctional cross-linking. In
such a scenario, even with reversible hydrolysis at one end of
the biomolecule, the stable attachment at the other prevents
release of the conjugate.278,279 However, as described below
oximes often provide a more suitable linkage for such
applications.
In contrast to hydrazones, oximes possess greatly improved
hydrolytic stability with the reaction equilibrium lying far
toward product formation (Figure 10). Even under acidic
conditions which promote hydrolysis, stable constructs can be
formed, although again stability is highly dependent on the
exact structure and local environment.272 As a result, oximes
have been more commonly utilized for the formation of
biomolecule-material conjugates. Esser-Kahn and Francis ﬁrst
reported the attachment of ketone or aldehyde modiﬁed green
ﬂuorescent protein (GFP)280 or metallothionein281 to
hydroxylamine-functionalized synthetic polymers (Figure 2).
Protein cross-linked hydrogels were produced through oxime
modiﬁcation at both the protein N- and C-termini. Oxime
formation has subsequently been utilized for the modiﬁcation
of hydroxylamine functionalized hydrogels with ketone-
modiﬁed adhesion peptides,282 the formation of cell supporting
glycopolymer ﬁlms,283 and the light-induced attachment of
aldehyde-functionalized proteins to photocaged hydroxylamine
gels235 (see section 8 for further details).
Despite these promising reports, the improved properties of
oximes over hydrazones, and the precedent for oxime ligation
in the ﬁeld of site-selective protein modiﬁcation,36,271 oxime
formation has yet to be fully embraced by the biomaterial
community as a means to undertake biomolecule conjugation.
Instead, the ﬁeld has primarily focused on the use of oximes to
Figure 9. Furan-functionalized hyaluronic acid hydrogels can be
cross-linked with a dimaleimide-functionalized peptide via Diels−
Alder cycloaddition. MMP-cleavable peptides enable the migration of
seeded breast cancer cells through the gel. Adapted with permission
from ref 269. Copyright 2015 John Wiley and Sons.
Figure 10. Addition of amines to aldehydes to form imines is a
reversible process, with equilibrium strongly favoring the starting
materials in aqueous solution. In contrast, hydrazones and oximes are
less susceptible to hydrolysis, providing the possibility for stable, but
reversible conjugation.
Figure 11. Reversibility of hydrazone formation enables materials to
possess self-healing properties. (a and b) Dye-loaded, hydrazone
cross-linked PEG-hydrogels are cut in half; (c−e) incubation for 7 h is
able to merge two halves placed together via reformation of hydrazone
linkages at the gel interface. Adapted with permission from ref 273.
Copyright 2010 American Chemical Society.
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form injectable, biocompatible, and mechanically tunable
materials for biomedical applications.275,282,284
In addition to the resultant stability and function of
hydrazone/oxime linkages, a number of other key consid-
erations should be taken into account during material design.
Although the kinetics of hydrazone/oxime formation are often
satisfactory for conjugation, in a dilute regime they may limit
product formation. Dirksen and Dawson reported that the
addition of a nucleophilic catalyst, such as aniline, can promote
hydrazone/oxime formation via an intermediate aniline-imine.
As a result, dramatic rate enhancements can be achieved in the
range of 10−1000 M−1 s−1.116,285,286 However, the high
toxicity of aniline prevents the beneﬁts of this adaptation being
exploited during conjugation in the presence of cells. Finally,
the potential toxicity of aldehyde reactive handles must be
considered. The propensity of aldehydes to transiently form
imines with amines present in biological systems may induce
cell death, particularly at high concentrations.278,287,288
Ketones oﬀer an alternative reactive handle for both hydrazone
and oxime formation in such scenarios. Although they are less
electrophilic, and thus form adducts at a reduced rate, the
lowered toxicity of ketones may prove beneﬁcial for
conjugation.282,287
5. ENZYME-MEDIATED CONJUGATION
Enzymatic methods for polypeptide conjugation have a
number of key advantages that set them apart from their
synthetic counterparts. Among these, the high sequence-
speciﬁcity, the ease of introducing reactive sequences via
mutagenesis, the mild conditions required for conjugation, the
tolerance of complex biological milieu, and the lack of
detrimental eﬀects on other biomolecules and cells are of
particular importance. Enzymatic-modiﬁcation of carbohy-
drates has typically been restricted to the extension,
remodelling, or trimming of preinstalled oligosaccharides and
thus falls outside the scope of this reviews. Readers are instead
directed to comprehensive reviews on this topic.289−291
Similarly, examples of enzymatic oligonucleotide conjugation
to biomaterial scaﬀolds are rare. In this section, we will
therefore focus on the key enzymes that have found use in
peptide and protein material conjugation (see Table 2).
5.1. Transglutaminase and Factor XIII
The transglutaminase enzyme family catalyzes the formation of
isopeptide bonds between the primary amine of lysine side
chains and the amide bonds of a complementary glutamine
residue. The resultant bonds are highly resistant to degradation
and are used in nature to form cross-linked networks of
insoluble protein. For example, the transglutaminase Factor
XIII plays an important role in triggering the coagulation of
blood.292,293 The substrate scopes of transglutaminases are
often broad, although preferred conjugation sequences have
been identiﬁed for speciﬁc enzymes based on their natural
cross-linking partners.
The ﬁrst example of transglutaminase-mediated hydrogel
formation was reported by Sperinde et al. (Figure 2). Tissue
transglutaminase (tTG) was used to induce the cross-linking of
a glutaminamide terminated PEG and a random copolymer of
lysine and phenylalanine residues.294 Although tTG favors
hydrophobic residues proximal to the lysine coupling partner
and the presence of glutamine repeats, it possesses low
sequence speciﬁcity and will cross-link a wide range of lysine/
glutamine functionalized sequences.295 This high promiscuity
limits the use of tTG for achieving site-speciﬁc conjugation. As
a result, tTG has been most commonly utilized for the cross-
linking of protein based materials.296,297
In contrast to the promiscuity of tTG, the transglutaminase
Factor XIII possesses improved sequence selectivity, though
over 150 Factor XIII substrates have still been identiﬁed from
natural cross-linking sites in human plasma alone.298 Schense
and Hubbell demonstrated that Factor XIII could be used to
conjugate RGD and DGEA peptides to ﬁbrin matrices by
appending native Factor XIII substrates prior to the bioactive
sequence, imparting nonﬁbrin properties.299 Although peptide
sequences functionalized with lysine reactive handles were
found to be more tolerant of substitution, reversing the
coupling partners and exploiting glutamine-containing sub-
strates resulted in higher conjugation eﬃciencies and a higher
density of bioactive sequence display.299,300 Since this initial
work, the use of Factor XIII to functionalize materials with
Table 2. Advantages, Disadvantages, and Selectivity of the Enzymatic Conjugation Strategies Outlined in Section 5
enzyme class advantages disadvantages selectivity
transglutaminases broad substrate scope promiscuity can limit site-selectivity sequence selectivity dependent on isoform
good availability conjugation between lysines and glutamine
residues
tolerant of sequence substitution often highly promiscuous with low selectivity
can be used with a wide variety of protein
substrates
peroxidases high availability requires added hydrogen peroxide oxidative conjugation between phenols, such as
tyrosine
broad substrate scope low selectivity sequence independent
small molecule and synthetic mimics
available
leads to thiol oxidation
reaction rate easily tuned
sortase high sequence speciﬁcity enzyme is expensive, limiting scale N-terminal “LPXTG” tag to a C-terminal
“GGG” tag
eﬃcient conjugation “tag” must be introduced very high speciﬁcity
peptide “tag” is short and minimally
disruptive
SpyTag-
SpyCatcher
inherently reactive peptide−protein pair SpyCatcher is a large and potentially
disruptive “tag”
very high speciﬁcity
potential for orthogonal pairs requires recombinant engineering of
biomolecule
aﬃnity can be tuned by structure alteration
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both peptide149,300−302 and protein149,303,304 based substrates
has become widespread, primarily due to the facile nature of
conjugation and the ease with which coupling sequences can
be incorporated into the polypeptide of choice. However, while
Factor XIII may be more selective than many other
transglutaminases, it is still able to catalyze the cross-linking
of a diverse range of substrates. Although this may be
advantageous in some scenarios, it may also limit selectivity
and lead to problems with cross-reactivity.
5.2. Peroxidase-Mediated Conjugation
Peroxidases catalyze oxidation of their substrates, most
commonly converting hydrogen peroxide to water in the
process. Horse radish peroxidase (HRP) is the most widely
utilized member of the peroxidase family, due to its ability to
oxidize a wide range of organic substrates. In the presence of
hydrogen peroxide, HRP can oxidize the phenol group of
tyrosine, as well as other electron-rich aromatic groups,
generating a highly reactive radical or quinone intermediate.305
Oxidised species then undergo spontaneous dimerization,
resulting in the formation of an ortho carbon−carbon bond
between two tyrosine residues.
During HRP-mediated conjugations the reaction kinetics
and eﬃciency are highly dependent on the precise
experimental conditions. Factors such as the enzyme and
hydrogen peroxide concentration, reaction temperature, pH,
and reagent structure can play a major role.306−308 Indeed, the
ﬂexibility this oﬀers is a generally beneﬁcial property of
enzyme-mediated conjugations over their chemical counter-
parts. During HRP catalysis an increase in hydrogen peroxide
concentration is typically associated with an increase in
reaction rate. However, above a critical peroxide concentration
enzyme inhibition begins to occur and a rapid drop-oﬀ in
oxidation activity is observed.309,310
HRP-mediated oxidation has been widely applied to cross-
link protein based materials, as well to nonspeciﬁcally attach
peptides and proteins to oxidation sensitive substrates.310−316
In contrast, there are relatively few reports on controlled HRP-
mediated conjugation. This is largely due to the need to
exclude exposed tyrosine residues from the surface of the
polypeptide of interest in order to ensure selectivity, as well as
the susceptibility of cysteine residues to HRP-mediated
oxidation. The Park group have reported the attachment of
pendant tyrosine-capped peptides to phenol-functionalized
tetronic and gelatin polymers in the presence of HRP and
hydrogen peroxide (Figures 12 and 2).317,318 A similar strategy
has been utilized by Menzies et al. to conjugate ﬁbronectin
derived peptides to PEG-based scaﬀolds.319 In these reports,
conjugation and scaﬀold cross-linking occur in parallel, with
fast reaction kinetics.
Singh et al. have demonstrated that, even in the absence of
added peroxide, the background auto-oxidation of thiol groups
is able to generate suﬃcient stoichiometric concentrations of
hydrogen peroxide to participate in HRP-mediated hydro-
gelation via disulﬁde formation.165 While this mechanism of
HRP action has not yet been utilized for peptide/protein
conjugation, it oﬀers intriguing possibilities for controlled
disulﬁde formation, as described in section 4.2.2. Alternatively,
the oxidizing enzyme laccase oﬀers possibilities for peptide and
protein conjugation in the absence of added peroxide, due to
its ability to utilize atmospheric oxygen to undertake phenol
oxidation, generating water as the only byproduct.320 Finally, a
large number of reagents able to mimic the activity of HRP
have been developed, which avoid the potential limitations of
Figure 12. HRP/H2O2 treatment can lead to the formation of diphenol linkages between tyrosine containing peptides and phenol-capped synthetic
polymers. In doing so, hydrogels bearing diﬀerent levels of pendant RGD peptides can be produced. (a−d) Phase contrast microscopy images of
seeded MC3T3-E1 cells at diﬀerent RGD grafting densities; (e−h) live/dead assay, green, living cells and red, dead cells; (i−l) F-actin (red,
phalloidin) and nuclei staining (blue, Hoechst 33258). Adapted from ref 317 with permission of The Royal Society of Chemistry.
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enzyme instability and environmental sensitivity. Many such
systems exploit metal complexes able to oxidize organic
substrates in the presence of hydrogen peroxide. For example,
Kakinoki and Yamaoka recently demonstrated the use of
copper-mediated tyrosine oxidation as a means to attach cell-
adhesive peptides to polymers, via the formation of an
intermediate reactive catechol motif.321
5.3. Other Enzymatic Methods
Over the last 15 years a number of short peptide “tags” have
been identiﬁed which are able to undergo eﬃcient enzymatic
modiﬁcation with high sequence speciﬁcity. These “tags”, as
short as 5 amino acids long, can be appended to a peptide or
protein substrate in order to allow their subsequent
modiﬁcation.322 Despite the interest in using these powerful
enzymatic strategies to undertake site-selective protein
modiﬁcation, particularly for cellular labeling, they have been
more rarely used for the formation of peptide/protein-
biomaterial conjugates. In an early example, Mosiewicz et al.
exploited the ability of phosphopatetheinyl transferases to
conjugate coenzyme A (CoA)-functionalized molecules to
carrier proteins to form peptide functionalized hydrogels.323
Although the carrier protein can be condensed down to a
peptide “tag” as short as 11 amino acids, the authors instead
used dimers of the full length protein to ﬁrst cross-link CoA-
functionalized PEG. The hydrogels were then further
derivatized using CoA-functionalized RGDS peptides.
Although conjugation was found to be slow compared to
alternative enzymatic methods for polypeptide conjugation,
functionalized materials could be produced in a highly speciﬁc
manner.
More recently, Cambria et al. reported the ligation of human
epidermal growth factor (hEGF) to PEG hydrogels, via the
action of the prokaryotic enzyme sortase (Figure 2).324,325 The
ﬁve amino acid long sortase “tag” LPXTG was ﬁrst introduced
into the hydrogel structure via Michael addition, as discussed
in section 4.2.1. Recombinantly expressed hEGF bearing the
C-terminal GGG motif required for sortase-mediated ligation
was then conjugated in the presence of an engineered sortase
derivative with enhanced reaction kinetics.326 Gao et al.
subsequently demonstrated that sortase could be used to
functionalize stimuli-responsive microgels with recombinant
proteins.327 Given the increasing prominence of sortase-
mediated protein modiﬁcation and reports on the optimization
of enzymatic activity and speciﬁcity, it is likely that such
reactions will ﬁnd increasing utility in biomaterial functional-
ization in the near future.328,329
Despite these important demonstrations of peptide “tag”
modiﬁcation for biomaterial functionalization, a number of
alternative prominent enzymatic modiﬁcation systems have so
far been largely overlooked by the biomaterials community,
including biotin ligase (discussed in further detail in section
9.4),330 formylglycine-generating enzyme,331 and lipoic acid
ligase332. This may be due in part to the large quantities of
enzyme required for eﬃcient biomaterial modiﬁcation, in
contrast to the small volumes required for traditional
applications such as intracellular labeling or the formation of
small molecule conjugates. This is particularly true when
considering the high cost of many of the enzymes noted in this
section, which severely limits the widespread application of
such techniques.
The need to introduce the “tag” into a protein target prior to
labeling may also prove limiting. However, in an exciting
recent development, Weeks and Wells have demonstrated that
mutant libraries of the peptide ligase subtiligase can be
generated with speciﬁcity for a wide range of N-terminal
dipeptide sequences. In doing so, the enzyme-mediated
modiﬁcation of native protein substrates will likely be enabled
without the need for prior engineering, and it is anticipated
that this work will have great impact on the biomaterial ﬁeld in
the coming years.333
Inherently reactive peptide sequences, which do not require
enzymes to induce conjugation, are an attractive alternative to
the systems described above. For example, peptides derived
from naturally occurring isopeptide linkages found in Gram-
positive bacteria have been shown to spontaneously cross-link
under mild conditions. The most prominent sequences are the
SpyTag-SpyCatcher peptide pair, derived from the ﬁbronectin-
binding protein of Streptococcus pyogenes.334,335 Sun et al.
demonstrated that this system could be used to cross-link and
functionalize suitably derivatized elastin-like protein hydrogel
networks with complementarily functionalized cytokines.336
Gao et al. subsequently reported the tethering of SpyTag-
modiﬁed proteins to SpyCatcher-functionalized hydrogels.337
Recent developments identifying orthogonal SpyTag-Spy-
Catcher pairs oﬀer intriguing possibilities for the generation
of multifunctional biomaterials.338
6. POLYMERIZATIONS OF LOW MOLECULAR
WEIGHT MONOMERS
Polymerization can be classiﬁed as proceeding via one of two
mechanisms, either chain-growth or step-growth. During
chain-growth polymerization, monomers are added at the
“active” end of a growing polymer chain, resulting in the
formation of high molecular weight materials even at low
conversions.339 In stark contrast, during step-growth polymer-
izations short oligomer chains couple to form polymeric
species, requiring high conversions in order to reach high
molecular weights. Both techniques can be used to form
biomolecule−polymer conjugates, though the free radical-
mediated chain-growth polymerization of vinyl monomers has
been by far the most popular method. The polymerization of
acrylate and methacrylate monomers has proven particularly
fruitful and has found widespread utility throughout material
science.340,341
In this section we will focus on the key aspects that make
chain-growth polymerizations suitable for the formation of
biomolecule−material conjugates. In particular, we will discuss
systems in which this is achieved through a monomer
prefunctionalized with the biomolecule of choice, commonly
referred to as a “grafting-through” approach.342 This is in
contrast to systems which rely on a biomolecule initiator
(“grafting-from”) or conjugation to a preformed polymer
(“grafting-to”). For a discussion of these techniques, as well as
a comprehensive overview of the ﬁeld of free-radical
polymerization, the reader is directed to a number of excellent
reviews on these topics.342−347
Among the most attractive features of free-radical polymer-
izations are their robustness, synthetic ease, and tolerance of
water, as well as the diversity of functionalized monomers that
can be utilized.341 Acrylate and methacrylate modiﬁed peptides
and glycans can be readily polymerized, representing one of
the oldest methods to produce materials bearing a high density
of pendant functionalities.199,348−351 Similarly, due to the
widespread availability of the synthetic oligonucleotide
phosphoramidite building block “Acrydite”, free-radical poly-
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merization remains one of the most common methods through
which to form DNA and RNA functionalized biomateri-
als.76,352−356 By undertaking polymerization in the presence of
a comonomer, the density of biomolecule presentation can be
easily tuned, allowing potential diﬃculties from steric
hindrance to be overcome.342 Initiation of polymerization
can be triggered by a number of means, including heat, UV and
visible light (as discussed in section 7.1), redox reactions, and
electrochemistry.357 Radical polymerizations have therefore
been widely adopted by the ﬁeld to produce functional
biomaterials.199,339,349−351,358,359 Indeed, acrylate modiﬁed
proteins can also undergo polymerization to produce func-
tional materials, while retaining biological activity.360,361
Although free-radical chain-growth polymerizations are
attractive for the formation of biomolecule conjugates, a
number of concerns with their use remain. Monomer toxicity
can be limiting when polymerization is undertaken in the
presence of cells. This is enhanced by the slow rate with which
chain-growth polymerizations approach complete monomer
conversion. Acrylates are particularly toxic, and as such
methacrylate based monomers are often used in cellularised
systems, albeit at the cost of reduced polymerization
kinetics.362 However, more signiﬁcantly the intrinsic radical
nature of the reactive species is in itself highly limiting. In
addition to imparting high sensitivity to oxygen,363 the
reactivity of the “active” chain-end can potentially damage
proteins, DNA/RNA, and cells via chain transfer.339 Although
damage can be partially mitigated in the presence of an excess
of reactive monomer, the danger of unforeseen drops in
conjugate activity still exist.
More recently “living” radical polymerizations (LRPs) have
emerged as attractive alternatives to standard free-radical
polymerizations. LRPs are controlled by a dynamic equilibrium
between a dormant chain and the active radical, minimizing
chain termination.346 The most commonly used LRPs for the
formation of bioconjugates include atom-transfer radical
polymerization (ATRP),364−367 reversible addition−fragmen-
tation chain transfer (RAFT) polymerization,365,368,369 and
nitroxide-mediated polymerization (NMP)370. Toxicity result-
ing from residual catalysts and metals, or the products of
RAFT agent cleavage, may be a potential drawback of LRP
techniques but is oﬀset by a greatly reduced active radical
concentration. This not only limits potential biomolecule
damage but also provides high control over molecular
structure, material architecture, and biomolecule distribu-
tion.46,342 Many exciting developments in the ﬁeld of LRP
are continuing to push forward our ability to synthesize
polymer−bioconjugates. While many cutting-edge techniques
are yet to ﬁnd application for biomaterial functionalization,
they provide exciting opportunities for future advances.
Readers are directed to a number of excellent recent reviews
which highlight the advantages provided by new LRP
methodologies and their potential advantages over currently
employed techniques in the biomaterial commun-
ity.345,347,371−373 For example, recent reports on cytocompat-
ible radical polymerizations using photoinduced electron
transfer (PET)-RAFT polymerization and oxygen tolerant
LRPs may overcome the limitations of traditional meth-
ods.373−375
In contrast to chain-growth polymerizations, step-growth
processes must reach high conversions to produce high
molecular weight materials. As a consequence, high molecular
weight “macromers” are often used to drive scaﬀold formation.
Most commonly this is achieved via the “polymerization” of a
suitably functionalized natural or synthetic macromer with a
multifunctional complementary cross-linker.339 Many examples
of such chemistries are discussed throughout the course of this
review, in the context of chemical or photoinduced
biomolecule conjugation techniques, and so will not be
discussed here. However, it should be noted that polymer
cross-linking reactions using radical or nucleophilic thiol−ene
reactions, CuAAC reactions, or hydrazone/oxime formation as
discussed above, all in eﬀect proceed via a step-growth
mechanism.
Table 3. Advantages, Disadvantages, and Selectivity of the Photo-Conjugation Strategies Outlined in Section 7
photoconjugation
strategy advantages disadvantages selectivity
acrylate-cross-
linking
versatile requires high radical concentrations thiols will also react with acrylates
high functional group tolerance highly damaging to biomolecules
acrylates can be toxic
thiol−ene greatly reduced radical concentration
required
even low radical concentrations potentially
damaging
alkene reactivity must be matched to thiol to prevent
chain transfer
stable radicals generated thiols often key for bioactivity
rapid reaction kinetics
allows 1-photon and 2-photon
patterning
low occurrence of cysteine enhances
selectivity
ease of introduction
thiol−yne greatly reduced radical concentration
required
even low radical concentrations potentially
damaging
alkyne reactivity must be matched to thiol to prevent
chain transfer
stable radicals generated thiols often key for bioactivity
more eﬃcient than corresponding
thiol−ene
slower than corresponding thiol−ene
reactions
results in bis-addition
allows 1-photon and 2-photon
patterning
low occurrence of cysteine enhances
selectivity
ease of introduction
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The step-growth polymerization of low-molecular weight
monomers has been far less commonly utilized. One such
system has been recently reported by the groups of Grubbs and
Tirrell, using the ring-opening metathesis polymerization
(ROMP) of peptide-functionalized strained norbornene
monomers, to produce functionalized ﬁlms that support cell
growth and adhesion.376 Building upon the work of Maynard
et al. in the early 2000s,377,378 eﬃcient ruthenium catalysts
were used to access high molecular weight polymers which
could be subsequently cross-linked to form free-standing ﬁlms.
Although these reports demonstrate the utility of peptide
monomers in producing functional biomaterials, they also
highlight the inherent limitations of using step-growth
polymerizations as a method for producing polypeptide
conjugates.
7. PHOTOCONJUGATION AND ACTIVATION
The use of light to instigate conjugation chemistry has
emerged over the last 25 years as a powerful technique in
the biomaterial ﬁeld. In particular, it oﬀers the opportunity to
control the spatial and temporal patterning and activity of
biomolecules, as well as to manipulate the physical structure of
a core scaﬀold.379 These photomediated techniques typically
generate a reactive radical species or cause bond scission to
generate a reactive intermediate which can subsequently
undergo bond formation. Ultraviolet (UV) irradiation has
long been used as an initiator for the polymerization and
conjugation of vinyl based monomers and functional
materials.380 However, recent trends toward less-cytotoxic
visible-light initiation systems,381 functionally selective con-
jugations which minimize biomolecule damage,105,382 and two-
photon excitation to allow precise 3D-patterning have
revolutionized the ﬁeld.383 Here, we will focus on the key
light-mediated techniques that have been used for direct
biomolecule-material conjugation (see Table 3). For a detailed
overview of the use of photosystems for controlling material
properties and prepatterning of reactive handles, as well as the
key technological developments which have enabled the
impressive control oﬀered by cutting-edge techniques, the
reader is referred to a number of comprehensive reviews in the
ﬁeld.383−386
7.1. Photoacrylate Cross-Linking
In section 6 we discussed the free-radical polymerization of
vinyl monomers, particularly acrylates and methacrylates
bearing pendant biomolecules. Polymerization is initiated by
the production of a radical species, which then propagates
through bond formation to create an “active” polymer chain
(Figure 13a). This key initiation step can be induced via a
number of stimuli, with thermal decomposition, redox
activation, and electrochemical ionization of an initiating
species being among the most common.357,387 Alternatively,
many initiators can be activated via light-induced photolytic
bond breakage (type I) or photoactivated abstraction of
protons from a co-initiator (type II).388 Photoinitiation oﬀers
the beneﬁts of being applicable across a wide temperature
range, using narrow and tunable activation wavelengths
dependent on the initiator used, rapidly generating radicals,
and the ability to control polymerization by removing the light
source.357,389 Importantly, the tolerance of polymerizations to
oxygen is greatly enhanced, enabling polymerization in the
presence of cells and tissues.390,391 The incorporation of
acrylate-functionalized peptides154,392−399 and pro-
teins394,400−406 during photopolymerization has therefore
been widely used as a method for producing biomaterial
conjugates. Alternatively, the photoinitiated attachment of
polypeptides to pendant vinyl groups on preformed materials
has also been widely reported and more recently used for 3D
patterning via two-photon excitation.121,398,403,407,408
A wide range of photoinitiators have found use in
photoacrylate conjugations. The ideal choice of initiator is
dependent on a number of factors, including the activation
wavelength, water solubility, and, perhaps most importantly in
the context of this review, biocompatibility of activation. Many
early reports of biomaterial formation and peptide function-
alization focused on the use of Eosin Y154,390 and 2,2-
dimethoxy-2-phenyl-acetophenone394,396,400 (commonly re-
Figure 13. Conjugation mechanism of (a) photoacrylate cross-linking; (b) photo thiol−ene reaction; and (c) photo thiol−yne diaddition.
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ferred to by its trade name Igracure 651). In subsequent years,
other initiators with improved cytocompatibility, such as
Igracure D2959, have come to prominence.399,402,404,406,409
Most recently, initiators with increased water solubility, such as
lithium phenyl-2,4,6-trimethylbenzoylphosphinate,410 or visible
light activatable systems such as riboﬂavin411,412 have become
more common.
Although acrylate and methacrylate based systems are most
prevalent, alternative activated alkenes can also undergo
polymerization, with vinyl sulfones displaying particularly
rapid cross-linking due to destabilization of the intermediate
radical species during propagation. Day et al. recently showed
that vinyl sulfone cross-linked hydrogels elicited a reduced
immune response in vivo when compared to the equivalent
acrylate-linked structure, though further investigation is
essential to assess the generality of this observation.413
Photoacrylate cross-linking has been widely used in the ﬁelds
of biomaterials and tissue engineering due to its ease of use.
However, such techniques are severely limited by the damage
caused to proteins, oligonucleotides, and cells by a
combination of UV light initiation, highly reactive acrylates,
and the propagating radical species generated during
conjugation. On its own, low wavelength UV light (<350
nm) can cause detrimental localized heating, protein
degradation, and DNA/RNA scission.414,415 When biomole-
cule-functionalized monomers are polymerized this problem is
exacerbated by the need for long UV exposure times, in order
to maintain the propagating radical species for long periods.
Protein activity can also be lost following the light-independent
modiﬁcation of lysine residues by reactive acrylates via Michael
addition.160,416 However, the most important limitation is the
damage caused by radicals following initiator activation. As
early as 2000, Bryant et al. highlighted the toxicity of a number
of UV photoinitiators including Igracures I184, I907, I651, and
D2959.417 The authors hypothesized that the nature of the
generated radical (methyl vs benzoyl) played an important role
in determining the level of toxicity observed. Of the initiators
investigated, Igracure D2959 was found to cause the lowest
levels of damage. These results were supported by Williams et
al., who also highlighted that diﬀerent cell types have altered
susceptibility to radical induced toxicity, with cells with high
proliferation rates most signiﬁcantly aﬀected.418 A number of
subsequent papers have discussed the origins of the observed
toxicity, with the persistence of radicals on growing polymer
chains,419 the generation of radicals following monomer
consumption,420 and the diﬀerence in initiator hydrophobic-
ity421 all being used to explain diﬀerences between initiators.
In addition to the toxicity caused to cells, the generation and
persistence of radicals is also highly detrimental to the activity
of tethered peptides, proteins, and oligonucleotides during
acellular biomaterial conjugation. Although there have been
conﬂicting reports on the degree and nature of the damage
caused, it is clear that even in cases where UV irradiation alone
does not cause signiﬁcant problems the generation of reactive
radicals can be highly damaging.160,420−422 In particular, the
generation of ROS as a result of the radical activation of triplet
oxygen has been shown to lead to protein cleavage and a
multitude of detrimental alterations to oligonucleotide
structure and function.423−426 Although drops in protein
activity can be partly mitigated by careful control of irradiation
strength, duration of application, and initiator choice, even
under such conditions the drop in bioactivity is still an
important consideration. As a result, although acrylate-cross-
linking is still widely used in the biomedical community it is
becoming increasingly unpopular for the conjugation of
biomolecule substrates to biomaterial scaﬀolds. Instead,
methods which require far lower radical concentrations, such
as those discussed in the following sections, have become more
favored.
7.2. Photo Thiol−ene Reactions
In section 4.2.1, we discussed the Michael addition of thiols to
electron-deﬁcient alkenes, so-called nucleophilic thiol−ene
reactions. Thiols can also react with alkenes via a free-radical
mechanism. A thiol radical ﬁrst reacts with an alkene to
generate a carbon-centered radical, which can then abstract a
proton from another thiol and thus propagate the reaction
(Figure 13b).427 This photo thiol−ene reaction oﬀers several
beneﬁts over photoacrylate cross-linking methods, including
rapid reaction kinetics, procedural simplicity and robustness,
lowered risk of nonproductive side reactions, and importantly
an even further reduced sensitivity to oxygen as a result of the
increased stability of thiol radicals.424 This radical stability also
leads to a signiﬁcant reduction in the number of radicals which
need to be generated for high conjugation eﬃciencies to be
achieved, with a concomitant reduction in damage to the cells
and biomolecules present.420 Many of the severe drawbacks of
photo-cross-linking reactions are therefore largely mitigated,
and photo thiol−ene reactions have emerged as the reaction of
choice for photopatterned conjugation, particularly of peptides
and proteins.105,130
A major advantage of the photo thiol−ene reaction is its
broad substrate scope. In order to achieve eﬃcient
conjugation, it is essential that the intermediate carbocation
induces propagation by regenerating a thiol radical, rather than
reacting with another “ene” to cause alkene-cross-linking and
chain transfer.427 Alkene choice is therefore largely determined
by the rate of conjugation, the ability to limit this damaging
chain transfer process, and importantly synthetic accessibility.
In contrast to their nucleophilic analogues, photo thiol−ene
reactions are generally accelerated by electron-rich alkenes,
which generate unstable carbon-radical intermediates able to
rapidly abstract thiol-hydrogens. Exceptions to this rule are
norbornene derivatives, in which reactivity is driven instead by
the release of ring strain upon thiol addition. This leads to a
general trend in reactivity of norbornene > vinyl ether >
propenyl > allyl ether > acrylate > maleimide.428 Norbornenes
and allyloxycarbonyls (alloc groups) have been particularly
widely used for peptide/protein-biomaterial functionalization,
due to the almost negligible contribution of chain transfer and
their ease of introduction during peptide synthesis, respec-
tively. In contrast to acrylate photo-cross-linking, the reactive
handles utilized in both cases are essentially inert to protein or
cellular substrates prior to irradiation, providing signiﬁcantly
improved speciﬁcity and temporal and spatial control.
In an early example, Polizzoti et al. demonstrated that the
alloc group, typically used as an orthogonal lysine protecting
group during solid-phase peptide synthesis, is an eﬃcient
photo thiol−ene reactive handle (Figure 14a). Alloc-function-
alized PEG hydrogels could therefore be photopatterned with
cysteine-capped RGDS peptides following irradiation in the
presence of Igracure D2959.198 Alloc groups have been
predominantly utilized for the patterning of pendant peptides
within PEG hydrogels, including through the use of visible
light and highly water-soluble photoinitiators (Figure
15).232−234,429,430 In a series of papers, the Anseth group
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subsequently demonstrated the power of norbornene reactive
handles for both the cross-linking and pendant functionaliza-
tion of synthetic polymers with cysteine capped peptides, in
the presence of Igracure D2959 (Figure 14b).117,258,431−435
Following these initial reports, a number of groups have gone
on to demonstrate the use of norbornene photo thiol−ene
reactions for the tethering and spatial patterning of bioactive
peptides and growth factor proteins.436−440
In addition to the most commonly used alloc and
norbornene reactive groups, other alkenes have also been
used for biomaterial functionalization. For example, codon
reassignment has been used to site-speciﬁcally incorporate
allyl-cysteine residues into proteins, which can subsequently
undergo conjugation through the use of photo thiol−ene
reactions.441 Alternatively, acrylates can undergo mixed-mode
photopolymerizations in the presence of cysteine capped
peptides,442,443 while allyl disulﬁde structures have recently
been shown to undergo reversible and controlled exchange of
conjugated thiols.444
As discussed in section 7.1, the generation of radicals upon
irradiation of photoinitiators can be highly detrimental to cell
viability and biomolecule activity.417,418,421 Although the
initiation of photo thiol−ene reactions proceeds via similar
mechanisms to those used for photoacrylate cross-linking, it
has been demonstrated that the damage caused is greatly
reduced. This can be attributed to a number of factors. First
and foremost, the rapid reaction kinetics and insensitivity to
oxygen of photo thiol−ene reactions enables the use of greatly
reduced irradiation times and initiator loadings. This in turn
limits radical concentrations, the generation of ROS, and
ultimately damage to cells, proteins, and oligonucleotides
(Figure 16).420,424 Indeed, thiol−ene reactions are able to
proceed eﬃciently with type II initiators even in the absence of
co-initiators, conditions which lead to highly ineﬃcient radical
formation.445 Second, it has been hypothesized that thiyl
radicals are less destructive to biomolecules than the carbon-
centered radicals generated during acrylate cross-link-
ing.419,420,446 Finally, the ability of thiol−ene reactions to be
propagated by ROS leads to the consumption of these highly
Figure 14. (a) Alloc- and (b) norbornene-handles are most widely
used for photo thiol−ene reactions and can be used to create 3D
patterns of pendant ﬂuorescently labeled peptides. Panel a is adapted
with permission from ref 198. Copyright 2010 American Chemical
Society. Panel b is adapted with permission from ref 117. Copyright
2009 John Wiley and Sons.
Figure 15. Two-photon activation can be used to induce photo thiol−
ene reactions with precise 3D resolution. In doing so, intricate
patterns of multiple ﬂuorescently labeled peptides can be sequentially
introduced into an alloc functionalized hydrogel. Scale bar = 100 μm.
Adapted by permission from Springer Nature: ref 234. Copyright
2011.
Figure 16. Comparison of (a) lysozyme and (b) TGF-β; bioactivity
following UV-irradiation in the presence of either acrylate-cross-
linking or thiol−ene photopolymerization reactive species. Irradiation
was continued until gelation occurred −180 s for acrylate cross-
linking, compared to just 10 s for thiol−ene reaction. Reproduced
with permission from ref 420. Copyright 2012 American Chemical
Society.
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reactive species, thus reducing the chance of associated damage
and toxicity.424,447
7.3. Photo Thiol−yne Reactions
Just as thiol−ene reactions can proceed via both nucleophilic
and radical mechanisms, so too can the related thiol−yne
reactions. In contrast to the products generated from Michael
addition, photo thiol−yne reactions undergo double thiol
addition to produce 1,2-bisaddition products. This is formally
achieved through an initial thiol−yne addition, followed by a
subsequent second thiol−ene step (Figure 13c).382 To date,
most examples of photo thiol−yne reactions have exploited
simple propargyl-ether or -amine reactive handles. Although
strained species such as cyclooctynes are also known to
undergo reaction, in an analogous fashion to the reaction of
thiols and strained norbornenes, the instability and high cost of
cyclooctyne derivatives may limit their usefulness as discussed
in section 4.3.2.448
Even though thiol−ene reactions are generally faster, thiol−
yne conjugations have been shown to take place with higher
eﬃciency, enabling the use of lower radical concentra-
tions.449,450 Despite this advantage, to date there are only a
few examples of the use of photo thiol−yne reactions for the
production of biomolecule−material conjugates. Costa et al.
demonstrated the functionalization of polymer brush surfaces
with adhesive RGD motifs.450 Indeed, cell adhesion to surfaces
modiﬁed by thiol−yne modiﬁcation was found to be greater
than those modiﬁed via a thiol−ene mechanism. Similarly,
Pedron et al. demonstrated the simultaneous photomediated
modiﬁcation of both alkene and alkyne groups for the spatial
patterning of polyglycerol hydrogels with adhesive peptides.451
8. PHOTOCAGING AND ACTIVATION OF REACTIVE
FUNCTIONALITIES
In the previous section, we focused on the use of light to
induce biomolecule conjugation. This discussion was framed
around the concept of generating a transient reactive species,
whether an acrylate or thiol derived radical. In addition to
these key reactions, light can also be used to treat
photoreactive handles which subsequently expose functionality
following irradiation. These so-called “photocaged” groups
Figure 17. Two-photon induced decaging of thiol-bromocoumarins enables photopatterning of agarose hydrogels. Through sequential
deprotection-conjugation steps, multiple peptides/proteins can be patterned with high 3D resolution. (a and b) 3D projections of patterned
hydrogels from diﬀerent angles, labeled with ﬂuorescent barstar (green) and streptavidin (red). Adapted by permission from Springer Nature: ref
463. Copyright 2011.
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have found widespread utility as a means to photopattern
biomaterial substrates. In contrast to the highly reactive
intermediates produced in situ during photoconjugation,
photocaging is more commonly used to mask or protect a
functional group until it is desirable for it to be exposed.452−454
Photocaging in the ﬁeld of biomaterials has most commonly
focused on the capping of thiol groups. The most widely
utilized “cages” are based around o-nitrobenzyl and coumarin
chromophores. In a pivotal paper, Luo and Shoichet
demonstrated that nitrobenzyl-capped cysteine residues could
be decaged by irradiation with 325 nm UV light. The released
thiol could then react with maleimide-functionalized peptides
via Michael addition, to generate a patterned hydrogel able to
guide cell migration.455 In these early reports, the limitations of
using single-photon irradiation restricted patterning to two
dimensions.455,456 With the advent of two-photon patterning
techniques, it was observed that o-nitrobenzyl groups were
poorly cleaved due to their poor two-photon absorption cross-
section. As a result, 6-bromo-hydroxycoumarins have become
the favored thiol-“caging” group within the biomaterials
community (Figure 17).457,458 The Shoichet group has been
particularly prominent in demonstrating the power of thiol-
“caging” for the patterning of growth factors with high spatial
precision, including VEGF,459 FGF,128 and EGF.172 Recent
reports on the increased decaging eﬃciency of methyl-
coumarin capping groups, as a result of reduced chromophore
isomerization upon irradiation, is likely to lead to a further
increase in conjugation eﬃciency.460 Although less commonly
investigated, reports on the nitrobenzyl-capping of amines461
for the “decaging” of Factor XIII substrates and hydroxyl-
amines235,462 for the spatially deﬁned patterning of proteins via
oxime ligation are also of note.
Although reactive promiscuity is a drawback for achieving
site-speciﬁc conjugation, the generation of a highly reactive
functionality in situ as a result of UV light irradiation enables
conjugation to take place based on proximity, rather than
chemical selectivity. This strategy has found widespread use in
the ﬁelds of chemical and cell biology, as a means to label a
biomolecule of interest with a probe brought into proximity
due to target binding. So called “photoaﬃnity probes” generate
a highly reactive intermediate upon irradiation, which then
reacts rapidly with the nearest accessible functional group with
high spatial precision.464 In the context of biomolecule
conjugation, such methods enable accurate photopatterning
to be achieved, albeit while sacriﬁcing the choice of
conjugation site.80,465−467 Although a number of photoreactive
groups are available, the most commonly used are phenyl-
azides, benzophenones, and phenyl-diazirines. Each has
advantages depending on the labeling strategy being pursued,
and the reader is referred to the excellent review of Smith and
Collins for further details.464
More recently, photocaged cycloadditions have emerged as a
potential means to achieve spatially deﬁned biomaterial
functionalization. In 2009, the Popik group demonstrated
that cyclopropenones could be used to mask latent cyclo-
octynes for SPAAC reactions and then decaged under UV
irradiation.468 These functional groups have subsequently been
used for the 2D patterning of ﬂat surfaces469,470 and more
recently for the generation of 3D patterns using two- and even
three-photon activation.471 Similarly, the UV irradiation of
tetrazoles has been shown to generate a reactive nitrile-imine
intermediate which can undergo rapid cycloaddition with
electron-deﬁcient alkenes such as acrylates or acrylamides.472
However, recent reports suggest that the selectivity and
orthogonality of such reactions may be low, with nitrile-imines
being found to react with a range of other biologically relevant
nucleophiles.473 Indeed, Feng et al. have exploited nitrile-imine
side-reactivity with thiols to site-speciﬁcally conjugate cysteine
containing proteins to tetrazole functionalized surfaces.474
Interestingly, reactions with carboxylic acid groups, widespread
on biomaterial surfaces, are most eﬃcient, though reaction
with alcohols and amines is also possible.473 Finally, the visible
light-activation of IEDDA reactions has recently been reported
by Truong et al. By conversion of an unreactive dehydro-
tetrazine to its active oxidized form, latent functionality can be
exploited to overcome the low stability of reactive functional
handles.475 These transformations are likely to come to
prominence in biomaterial functionalization in the coming
years, combining the high speciﬁcity and fast reaction kinetics
of cycloadditions, with the spatial precision associated with
photoactivation.
Table 4. Advantages, Disadvantages, and Selectivity of the Noncovalent Conjugation Strategies Outlined in Section 9
conjugation strategy advantages disadvantages selectivity
binding sequences can be evolved to target of interest aﬃnity of short sequences is often low dependent on target and sequence. Often high
enable recruitment of biomolecules
in vivo
aptamers prone to degradation diﬃcult to distinguish similar biomolecules
allow postfabrication modiﬁcation
self-assembling
peptides
high density of display readily
achieved
large ligands may disrupt assembly N/A, synthesized sequence
properties easily tuned
host−guest chemistry often high stability guest must be introduced into biomolecule very high, dependent on system
reversible display can be triggered
orthogonal to native systems
biotin−(strept)avidin very high stability and rapid
conjugation kinetics
streptavidin introduces large bulk into
constructs
very high. Biotin and biotin-binding proteins are very
rare in native systems
mostly orthogonal to native
systems
biotinylation requires low speciﬁcity or
recombinant synthesis
easy to undertake and robust
nucleic acids multiplexed conjugation possible DNA/RNA low stability very high; determined by sequence complementarity
high speciﬁcity and robust display high cost, even for PNAs
forms stable conjugates
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9. NONCOVALENT SYSTEMS
While the conjugation techniques discussed so far rely on
forming covalent bonds between the molecules of interest and
the biomaterial, there is a growing set of tools which utilize
noncovalent interactions to achieve similar goals. Noncovalent
binding plays a vital role in cells, controlling biomolecular
interfaces and inﬂuencing protein−protein interactions, DNA−
DNA complexation, DNA−protein interfaces, protein local-
ization, and more.476 These motifs, along with unnatural
functional groups, have been used for both the modiﬁcation
and engineering of biomolecules of interest. Here, we provide a
brief summary of the most commonly applied noncovalent
systems utilized by researchers for the functionalization of
biomaterials (see Table 4).
9.1. Binding Sequences
A signiﬁcant challenge in incorporating bioactive factors into
biomaterials is that the conjugation chemistry often dictates
that additional functional groups must be added to the
molecules of interest, or else functional groups present on the
native biomolecule must be used for covalent coupling. Both of
these methods can lead to a reduction in bioactivity. Many
groups have therefore been interested in utilizing noncovalent
sequences which display a binding aﬃnity for the biomolecule
of interest, allowing for postfabrication modiﬁcation or for
native biomolecules to be simply sequestered from the
surroundings within biological samples.
The most commonly used binding sequences are short
peptides between 7 and 20 amino acids in length, derived from
a variety of sources, including known protein binding domains
present in vivo477 or determined through techniques such as
phage display478. Though peptide sequences have the
advantage of being easily synthesized and modiﬁed with
functional groups for conjugation, their binding aﬃnities
toward biomolecules tend to be signiﬁcantly weaker than those
of full length proteins. Short oligonucleotides known as
aptamers can also be used to bind a variety of protein
substrates, including the cytokines vascular endothelial growth
factor (VEGF)479 and platelet derived growth factor
(PDGF),480 as well as cell surface proteins such as epidermal
growth factor receptor (EGFR)481. Indeed, many of the
examples of biomaterial−oligonucleotide conjugation de-
scribed in this review act as a means to subsequently bind
and control the release of growth factors, cytokines, and ECM
proteins.76,158,352,353,355,356,482 DNA and RNA are inherently
less stable than peptides and often more expensive to access
synthetically. However, the ability to access long aptamer
sequences is attractive, allowing the production of constructs
with increased binding aﬃnity. It is also possible to incorporate
multiple binding motifs on a single DNA strand, allowing the
colocalization of two separate proteins or biomolecules.483
An emerging technology in material binding is that of
molecular imprinting.484,485 In such systems, recognition
domains are imparted into a polymerized surface via
templating, subsequently allowing the display of bioactive
sequences. Pan et al. recently showed that such a technique
could be used to reversibly control cell adhesion and spreading,
via the attachment of RGD.486
Adding an extra layer of complexity, binding sequences can
also be introduced into a biomaterial with aﬃnity for native
biopolymers, such as heparin. The ability of such polymers to
bind and activate secreted proteins is a key and often
overlooked step in many cell signaling processes. As such, by
ﬁrst inducing biopolymer binding, the adsorption of an added
or endogenous growth factor or signaling protein to a
biomaterial scaﬀold can then be controlled.9,487,488
Finally, binding aﬃnity at the amino acid level can also be
exploited to enable peptide and protein conjugation to certain
biomaterial substrates. In particular, the binding of unnatural
catechol-based amino acids can be used to induce binding to
metal oxide containing bioglasses489,490 and metallic im-
plants,491 enabling the bioactivity of these important
technologies to be enhanced.
9.2. Self-Assembling Peptides
Native peptides and proteins adopt a series of secondary
structures, including β-sheets and α-helices, which can both
stabilize individual sequences and control interprotein
aggregation. One of the simplest methods to noncovalently
incorporate biological motifs into a biomaterial scaﬀold is to
exploit these self-assembly processes to form the material itself.
Self-assembling peptides have been used extensively to
assemble hydrogels and ﬁbrous materials, and the reviewer is
referred to a number of comprehensive reviews for an overview
of the ﬁeld.492−495 In many of these structures, biological
epitopes or functional groups can be appended to some or all
of the peptide building blocks during peptide synthesis, to add
the desired bioactivity into the system. Peptide-ligands ranging
from simple adhesion motifs, to laminin derived epitopes,496
and growth factor mimetics497 have all been displayed on the
surface of self-assembled ﬁbrils (Figures 18 and 2).
Alternatively, glycopeptides can be assembled in order to
recruit extracellular signaling proteins and growth fac-
Figure 18. (a) Illustration of a VEGF-mimicking peptide amphiphile,
self-assembling to form nanoﬁbres; (b) quantiﬁcation of muscle
capillary density within a murine hind-leg ischemia model following
the administration of peptide amphiphile (VEGF PA), VEGF
mimicking peptide, a mutant amphiphile, or control treatment,
based on the staining of CD31 positive capillaries; Reproduced with
permission from ref 497. Copyright 2011 National Academy of
Sciences.
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tors,498,499 mimic glycosylation patterns within hyaluronic
acid,500 or investigate optimal sulfonation ratios in glyco-
saminoglycan scaﬀolds.501 Increased activity can be achieved as
a consequence of the ability to create high densities of epitope
display on the surface of the nanoﬁber and to recreate the
multivalent displays commonly present in native ECM. Self-
assembling domains can also be added to full-length proteins,
leading to the incorporation of pendant functionality during
hydrogel formation.502
The propensity of peptides to form secondary structures has
also been exploited within nonself-assembling scaﬀolds. This is
most easily achieved by mixing a self-assembling peptide into a
covalent hydrogel, composed of either a noninteracting
polymer such as interpenetrating networks of PEG503 or
systems where additional charge interactions further stabilize
the ﬁnal construct, for example between positively charged
peptides and negatively charged alginate gels.504 As an
alternative, pendant helical groups can be attached to a
covalent material and used to drive the noncovalent attach-
ment of bioactive groups such as growth factors via self-
assembly into coiled-coil triple helices.505
9.3. Host−Guest Chemistry
Host−guest chemistry has recently had a surge in popularity in
the biomaterials ﬁeld, due to the ease of polymer modiﬁcation,
the relatively low costs of reagents, and the ability to tailor
binding aﬃnities to the desired application. Host−guest
chemistry can be used to dynamically modify the bioactivity
of hydrogels during cell culture. For example, Boekhoven et al.
demonstrated that the adhesive properties of a β-cyclodextrin
modiﬁed alginate scaﬀold could be controlled in situ through
the addition of a guest naphthyl-functionalized RGDS peptide
(Figures 19 and 2).506 By subsequently introducing a non-cell
adhesive adamantane-RGES peptide with a higher host binding
constant, dynamic modulation of ﬁbroblast cell attachment was
enabled. Interestingly, at low RGD concentrations no guest-
dependent eﬀects were seen on cell spreading. However, at
higher concentrations, signiﬁcantly reduced cell spreading was
induced by naphthyl-functionalized peptide when compared to
the analogous adamantane system. The authors attributed this
eﬀect to the aggregation states of the unbound peptide. This
hypothesis acts as an important reminder that noncovalent
systems exist in a dynamic state, adding an additional layer of
complexity during biomaterial design.
Host−guest chemistry has also been used as a supra-
molecular tool to build a system capable of binding growth
factors. A guest molecule with a strong nickel-binding aﬃnity
was ﬁrst bound to a material-tethered host molecule.507 This
nickel species was then used to induce the aﬃnity-binding of
polyhistidine-tagged proteins, such as anti-BMP antibodies,
which in turn were capable of sequestering native BMP.
9.4. Biotin−(Strept)avidin
Avidin and streptavidin are homotetrameric proteins able to
simultaneously bind up to four molecules of their small
molecule binding partner biotin. The biotin−(strept)avidin
aﬃnities are among the strongest known noncovalent
interactions, with dissociation constants in the range of
10−14−10−15 M. The small size of biotin (with a mass of just
244 Da) and the ease with which it can be functionalized via its
free carboxylic acid has led to biotin−(strept)avidin binding
ﬁnding widespread use as a means to undertake biomaterial
conjugation. Aﬃnities are high enough to limit diﬀusion or loss
of conjugate binding, providing largely stable devices under
physiological conditions.508,509 Streptavidin−protein fusions
can be produced recombinantly and bound to suitably
functionalized surfaces to achieve conjugation.509,510 More
commonly, biomolecule biotinylation is undertaken, and this
construct is then bound to a (strept)avidin functionalized
surface. This can either be achieved by a direct route, via
chemical preconjugation of the material with (strept)-
avidin,463,508,511 or by exploiting the tetrameric binding of
(strept)avidin to mediate indirect modiﬁcation or cross-linking
of biotin-functionalized scaﬀolds.512,513 However, the use of
large proteins to mediate conjugation (streptavidin has a mass
of ∼53 kDa and avidin of ∼68 kDa) can prove problematic,
introducing a large steric hindrance to normal material and
cellular behavior.509 Furthermore, the multimeric binding
capabilities of a single (strept)avidin partially reduces control
over the orientation of biomolecules following biomaterial
conjugation.
The biotinylation of proteins and growth factors can be
undertaken via nonspeciﬁc lysine modiﬁcation, as discussed in
section 4.1.508 Alternatively, the protein-modifying enzyme
biotin ligase, ﬁrst introduced in section 5.3, can be used to
induce site-speciﬁc biotinylation of a complementary peptide
sequence, recombinantly combined with the protein of
interest. Successive optimizations have led to the identiﬁcation
of a short 15-amino acid peptide “tag”, commercially known as
Figure 19. (a) Host−guest interactions between cyclodextrin and
naphthyl- or adamantane-functionalized peptides allow alginate
functionalization; Confocal microscope images of 3T3 ﬁbroblasts on
functionalized substrates: (b) without peptide, (c) 10 μM naphthyl-
RGDS, and (d) 10 μM adamantane-RGDS. Scale bar = 10 μm. (e)
Quantiﬁcation of cell spreading on substrates in the presence of
various guests. Adapted with permission from ref 506. Copyright 2013
John Wiley and Sons.
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AviTag, that enables eﬃcient biotinylation.514−516 Recombi-
nant expression has therefore been exploited to allow
prebiotinylation and subsequent biomaterial conjugation with
a wide range of cytokines and growth factors, including
interferon-γ (IFN-γ), platelet-derived growth factor (PDGF),
and BMP-2.517−519
Biotin−(strept)avidin binding is commonly viewed as being
irreversible. Though this is not truly the case, with biotinylated
biomolecules continuing to undergo reversible binding albeit at
very slow rates, it is diﬃcult to induce signiﬁcant cleavage of
biotin−biomaterial conjugates.514 As an alternative, Lambert et
al. recently utilized a biotin analogue, desthiobiotin, with
signiﬁcantly reduced aﬃnity to provide reversible presenta-
tion.509,520 Although binding was still strong (association
constant of ∼10−11 M), streptavidin functionalized peptides
could be cleaved from desthiobiotin modiﬁed surfaces by the
addition of competitive biotin. The tolerance of biotin ligase
for desthiobiotin substrates oﬀers intriguing possibilities for
this technology, though it is important to note that to achieve
multiple cycles of reversibility, biomolecules must be function-
alized with (strept)avidin, rather than biotin.521
9.5. Nucleic Acids
In this review we have discussed several methods through
which biologically active oligonucleotides can be conjugated to
a biomaterial scaﬀold. In an analogous fashion to self-
assembling peptides, nucleic acids can also form assembled
materials themselves, to generate tunable platforms for the
display of biomolecules. While covalent conjugations and
host−guest chemistries oﬀer the possibility to add functionality
to a biomaterial, both before and after cell seeding, combining
multiple orthogonal reactions to display more than one motif
within a single scaﬀold can be both synthetically and
conceptually challenging. DNA and RNA oﬀer a solution to
this diﬃculty, as an arbitrary number of sequences can be made
which can preferentially bind a complementary strand with
high speciﬁcity. Nucleic acids have mostly been utilized to
either modify biomaterial mechanical properties or to
controllably deliver nucleic acid strands to cells. However,
reports have demonstrated that DNA-tagged peptides and
growth factors can be conjugated to a suitably functionalized
biomaterial and used to elicit a desired biological eﬀect on a
localized cell population. Recently, synthetic techniques have
been developed for the template-directed, site-selective DNA
modiﬁcation of proteins which oﬀers great possibilities for this
emerging technology.507
Despite the promise of nucleic acids as a means for
biomaterial functionalization, their large size (a 10-mer
typically has a mass >3 kDa) is potentially disruptive to
protein activity and both DNA and RNA are inherently prone
to degradation. Peptide nucleic acids (PNAs), featuring an
unnatural backbone composed of amide bonds, have recently
emerged as viable alternatives to combine the chemical
stability of peptides with the speciﬁcity of DNA. The ability
to synthesize PNA via peptide synthesis techniques enables the
facile and automated fabrication of peptide−PNA conju-
gates.522,523 These structures have been utilized in the
biomaterial ﬁeld for a variety of applications, including the
conjugation of oligonucleotide sequences524 and the cross-
linking of hydrogels.525 The PNAs themselves can have
unusual properties, including ﬂuorescence emission from
structures containing as little as two bases.526 In addition to
their ability to be covalently coupled to polymers, PNAs have
also been utilized as hydrophilic domains within self-
assembling amphiphilic polymer systems, able to bind
complementary DNA sequences and form nanostruc-
tures.527,528 However, although the chemical stability and
structural plasticity of PNAs is attractive for further
applications in biomolecule-material conjugation, their high
cost, at roughly 100× that of standard amino acids, is currently
limiting to their widespread use.
10. INCORPORATING REACTIVE HANDLES
When designing a biomolecule-material composite, the choice
of conjugation technique often requires a compromise between
ease of use and site-speciﬁcity, as discussed in section 3. While
lysine residues can be easily modiﬁed on virtually any synthetic
or natural polypeptide substrate, their common occurrence
often leads to heterogeneous mixtures of modiﬁed materials,
typically at the detriment of biological activity. In contrast,
though IEDDA reactions can be engineered to occur with
exquisite precision and site-speciﬁcity, the synthesis of the
required reactive handles and their subsequent incorporation
into the reactive partners can prove challenging. In this section
we will brieﬂy discuss the key methods for introducing
uniquely reactive motifs into biomolecule substrates, providing
a chemical “tag” which allows single-site selectivity or
speciﬁcity to be achieved.529
Short peptides and oligonucleotides can typically be
produced via solid phase synthesis (SPS). The versatility of
organic synthesis allows diﬃculties in reactive handle
incorporation to be overcome, with a wide range of suitably
functionalized amino acids and oligonucleotides avail-
able.22,530,531 While some of the reactive handles described
in this review may be more synthetically challenging than
others, virtually all are now commercially available (though
sometimes at high cost) in a form that is compatible with
standard Fmoc- or phosporamidite-based SPS. In contrast, the
synthesis of functionalized glycans is far more intensive.
Analogous solid-phase techniques for carbohydrate synthesis
remain limited to specialist laboratories, and often require
signiﬁcant optimization.53,55 Solution-phase synthesis therefore
remains the method of choice for glycan-derivatization, and the
installation of reactive handles within substrates more complex
than simple mono- or disaccharides often requires extensive
synthetic eﬀorts. Chemo-enzymatic methods for the function-
alization of complex, naturally derived polysaccharides are
therefore critical in order to allow selective biomaterial
conjugation.532
The installation of unique reactive handles in larger protein
substrates remains more challenging. Among the 21 natural
amino acids, cysteine provides a unique opportunity to achieve
site-selective modiﬁcation due to its low natural abundance
and high nucleophilicity, as described in section 4.2. The
targeting of native cysteines on protein surfaces, or the
introduction of a single residue into recombinantly expressed
proteins by site-directed mutagenesis, allows selective thiol
conjugation to be achieved.49 While other natural amino acids
can in principle be targeted, in practice this is complicated by
their common occurrence on protein surfaces, and the
resultant loss in selectivity this causes. However, there are
many elegant examples in which impressive selectivity has been
achieved by such means, and the reader is referred to a number
of reviews that discuss such methods in detail.36,60−62,533
An alternative approach is to introduce unnatural amino
acids (UAAs) bearing the desired reactive handles (Figure 20).
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This is often achieved via the modiﬁcation of lysine residues
with amine-reactive derivatives, largely negating any strategic
advantage to the introduction of the unnatural structure.
However, a number of powerful methods have been developed
for the introduction of UAAs during the translation of
recombinantly produced proteins. Among the earliest to be
introduced was the use of auxotrophic bacterial strains, which
are unable to biosynthesise a particular amino acid and thus
require uptake from the growth media. By starving the bacteria
of the native amino acid and supplementing it with a
structurally related unnatural analogue, the bacterial cells can
be “tricked” into incorporating the UAA during translation.
This technique has been widely used to install azide- and
alkyne-based mimics of methionine, leading to the introduc-
tion of reactive handles for undertaking CuAAC and SPAAC
reactions.534−537 Analogous strategies can be used for the
incorporation of unnatural monosaccharides, enabling the
remodelling of complex glycans. These technologies have most
commonly been exploited for metabolic labeling.538,539
However, in a notable example Iwasaki et al. demonstrated
that the subsequent isolation of modiﬁed glycoproteins bearing
methacrylated sialic acid motifs could be used to functionalize
hydrogel scaﬀolds.540
Auxotrophic strains oﬀer a useful means to introduce certain
reactive structures. However, their use is limited in scope to
structurally similar UAAs recognized by the natural cell
translational machinery. A far more powerful technique is the
use of codon reassignment using orthogonal tRNA and tRNA
synthetase pairs that selectively recognize and charge an UAA
during translation. This has been most commonly achieved by
reassigning the amber “stop-codon”, UAG, by incorporating a
tRNACUA/tRNA synthetase pair from an alternative kingdom
into the host cell. This pair is able to install the desired UAA,
while being eﬀectively invisible to the endogenous cell
machinery. As a result, site-directed mutagenesis can be used
to introduce a single TAG codon at the desired position of the
coding DNA, leading to the singular introduction of the UAA
with high speciﬁcity and selectivity. Since the pioneering work
of the Schultz group and others in the late 20th century,541
codon-reassignment has developed into a powerful technique
at the cutting-edge of molecular biology and protein science.
Recent examples of UAA incorporation in mammalian cells
and even living animals are at the forefront of the ﬁeld.542 A
large number of excellent reviews have been published on this
topic, and the reader is directed toward these for a detailed
overview of the key technologies and applications in which
codon reassignment is ﬁnding use.50,542−544 However, in the
context of this review the key beneﬁt of this technique is its
ability to introduce a versatile range of unnatural reactive
handles which cover virtually all of the reaction classes
discussed here, as outlined in detail by Dumas et al.50 Although
to date codon reassignment has only rarely been used in the
ﬁeld of biomaterial conjugation, this is largely due to the far
from widespread availability of the requisite plasmids.225,366,441
As the tools and techniques required become more common-
place, these methods are likely to become more prominent in
biomaterial−protein conjugate technologies.
11. OUTLOOK
The formation of biomolecule−material conjugates remains a
major challenge in the biomedical ﬁeld. While a vast amount of
eﬀort has been devoted to the development of generalized
techniques to achieve controlled, reproducible, and eﬀective
conjugation, it is clear that no perfect conjugation technique is
available. It is now common to talk of the “holy grail” of
bioconjugation, a reaction that can combine ease of use,
conjugation eﬃciency, chemo-selectivity, and substrate versa-
tility. However, in truth achieving one global method is
unrealistic.36 The best technique available in a certain scenario
is highly dependent on the precise construct and must be
carefully considered during material design.17 It is our opinion
that researchers must carefully ask questions before embarking
on the design and synthesis of a functionalized biomaterial.
Perhaps most obviously, what is the nature of the scaﬀold, the
biomolecule coupling substrate, and the end application? Is
conjugation being undertaken under cellular or acellular
conditions? Is spatial control or dynamic attachment required?
Beyond these questions lay other less obvious considerations,
particularly when moving toward clinical translation. Are the
functional precursors stable to storage? How reproducibly and
homogeneously can conjugation be achieved? Is production of
the required reactive partners commercially viable? Are
eﬃciencies maintained during scale-up?
On paper, modiﬁcation strategies targeting amines or thiols
can seem strategically clumsy, oﬀering low selectivity and often
diminished activity.61 Yet these techniques persist across the
academic literature and even in industry. This may in part be a
case of habit, or it could be the consequence of a lack of
expertise to enable the implementation of other more
Figure 20. Examples of some of the conjugation-handles that can be site-selectively incorporated into proteins via codon reassignment. These
include reactive motifs for nucleophilic and photo thiol−ene reactions, cycloadditions, aldehyde functionalization, host−guest chemistry, and
photocaging.
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challenging conjugation strategies.48 It may also be that, while
a drop in bioactivity seems unpalatable, an end-device with
acceptable performance can still be achieved, and so any
downsides are greatly outweighed by the ease of implementa-
tion and cost. In contrast, the incorporation of an unnatural
reactive handle into a bioactive motif may seem an overly
challenging and time-consuming proposition, requiring sig-
niﬁcant optimization, cost, and heartache, merely to produce
the coupling partner, before even considering the diﬃculties
associated with conjugation.545 However, if controlled
orientation and a signiﬁcant improvement in bioactivity can
be achieved, potentially facilitating regulatory approval, then
this initial eﬀort may prove worthwhile.546
Although signiﬁcant strides have been made over the past 20
years, there is still much scope for improving the eﬀectiveness
of biomaterial-based technologies. We believe that further
innovation is required within the chemical biology and
biomedical ﬁelds and, perhaps more importantly, greater
dialogue and collaboration between researchers from the two
communities. By doing so, elegant solutions to the problems
which continue to dog biomaterial conjugates will be achieved.
However, it is vital that developments are translatable to
biomedical scenarios and oﬀer real advantages over existing
technologies. Potent peptides able to recapitulate the biological
activities of proteins, improved and widely available methods
for installing unnatural reactive handles, modular scaﬀolds that
allow facile and versatile modiﬁcation, highly selective
conjugation handles that can be easily and cheaply introduced,
and patterning techniques with improved biocompatibility are
all highly desirable and can only be achieved through
innovative interdisciplinary research.
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Formation in Polymer Networks: A Versatile Functional Group from
Synthesis to Applications. Eur. Polym. J. 2013, 49, 1268−1286.
(136) Lyon, R. P.; Setter, J. R.; Bovee, T. D.; Doronina, S. O.;
Hunter, J. H.; Anderson, M. E.; Balasubramanian, C. L.; Duniho, S.
M.; Leiske, C. I.; Li, F.; et al. Self-Hydrolyzing Maleimides Improve
Chemical Reviews Review
DOI: 10.1021/acs.chemrev.8b00253
Chem. Rev. 2018, 118, 7702−7743
7732
the Stability and Pharmacological Properties of Antibody-Drug
Conjugates. Nat. Biotechnol. 2014, 32, 1059−1062.
(137) Fontaine, S. D.; Reid, R.; Robinson, L.; Ashley, G. W.; Santi,
D. V. Long-Term Stabilization of Maleimide-Thiol Conjugates.
Bioconjugate Chem. 2015, 26, 145−152.
(138) Kalia, D.; Pawar, S. P.; Thopate, J. S. Stable and Rapid Thiol
Bioconjugation by Light-Triggered Thiomaleimide Ring Hydrolysis.
Angew. Chem., Int. Ed. 2017, 56, 1885−1889.
(139) Morais, M.; Nunes, J. P. M.; Karu, K.; Forte, N.; Benni, I.;
Smith, M. E. B.; Caddick, S.; Chudasama, V.; Baker, J. R.
Optimisation of the Dibromomaleimide (DBM) Platform for Native
Antibody Conjugation by Accelerated Post-Conjugation Hydrolysis.
Org. Biomol. Chem. 2017, 15, 2947−2952.
(140) Kalia, D.; Malekar, P. V.; Parthasarathy, M. Exocyclic Olefinic
Maleimides: Synthesis and Application for Stable and Thiol-Selective
Bioconjugation. Angew. Chem., Int. Ed. 2016, 55, 1432−1435.
(141) Lutolf, M. P.; Raeber, G. P.; Zisch, A. H.; Tirelli, N.; Hubbell,
J. A. Cell-Responsive Synthetic Hydrogels. Adv. Mater. 2003, 15,
888−892.
(142) Lutolf, M. P.; Lauer-Fields, J. L.; Schmoekel, H. G.; Metters,
A. T.; Weber, F. E.; Fields, G. B.; Hubbell, J. a. Synthetic Matrix
Metalloproteinase-Sensitive Hydrogels for the Conduction of Tissue
Regeneration: Engineering Cell-Invasion Characteristics. Proc. Natl.
Acad. Sci. U. S. A. 2003, 100, 5413−5418.
(143) Lutolf, M. P.; Weber, F. E.; Schmoekel, H. G.; Schense, J. C.;
Kohler, T.; Müller, R.; Hubbell, J. A. Repair of Bone Defects Using
Synthetic Mimetics of Collagenous Extracellular Matrices. Nat.
Biotechnol. 2003, 21, 513−518.
(144) Zisch, A. H.; Lutolf, M. P.; Ehrbar, M.; Raeber, G. P.; Rizzi, S.
C.; Davies, N.; Schmökel, H.; Bezuidenhout, D.; Djonov, V.; Zilla, P.;
et al. Cell-Demanded Release of VEGF from Synthetic, Biointeractive
Cell-Ingrowth Matrices for Vascularized Tissue Growth. FASEB J.
2003, 17, 2260−2262.
(145) Cheng, F.; Shang, J.; Ratner, D. M. A Versatile Method for
Functionalizing Surfaces with Bioactive Glycans. Bioconjugate Chem.
2011, 22, 50−57.
(146) Wang, H.; Cheng, F.; Li, M.; Peng, W.; Qu, J. Reactivity and
Kinetics of Vinyl Sulfone-Functionalized Self-Assembled Monolayers
for Bioactive Ligand Immobilization. Langmuir 2015, 31, 3413−3421.
(147) Park, Y.; Lutolf, M. P.; Hubbell, J. A.; Hunziker, E. B.; Wong,
M. Bovine Primary Chondrocyte Culture in Synthetic Matrix
Hydrogels as a Scaffold for Cartilage Repair. Tissue Eng. 2004, 10,
515−522.
(148) Rizzi, S. C.; Hubbell, J. A. Recombinant Protein- Co -PEG
Networks as Cell-Adhesive and Proteolytically Degradable Hydrogel
Matrixes. Part I: Development and Physicochemical Characteristics.
Biomacromolecules 2005, 6, 1226−1238.
(149) Ehrbar, M.; Rizzi, S. C.; Hlushchuk, R.; Djonov, V.; Zisch, A.
H.; Hubbell, J. A.; Weber, F. E.; Lutolf, M. P. Enzymatic Formation of
Modular Cell-Instructive Fibrin Analogs for Tissue Engineering.
Biomaterials 2007, 28, 3856−3866.
(150) Patterson, J.; Hubbell, J. A. Enhanced Proteolytic Degradation
of Molecularly Engineered PEG Hydrogels in Response to MMP-1
and MMP-2. Biomaterials 2010, 31, 7836−7845.
(151) Seliktar, D.; Zisch, A. H.; Lutolf, M. P.; Wrana, J. L.; Hubbell,
J. A. MMP-2 Sensitive, VEGF-Bearing Bioactive Hydrogels for
Promotion of Vascular Healing. J. Biomed. Mater. Res. 2004, 68A,
704−716.
(152) Hartwig, A.; Brand, R. H.; Pfeifer, C.; Dürr, N.; Drochner, A.;
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Martínez-Saeź, N.; Albuquerque, I. S.; Perkins, E.; Corzana, F.;
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L.; Kraĺ, P.; Gianneschi, N. C. Poly(Oligonucleotide). J. Am. Chem.
Soc. 2014, 136, 11216−11219.
(528) Liu, L.-H.; Li, Z.-Y.; Rong, L.; Qin, S.-Y.; Lei, Q.; Cheng, H.;
Zhou, X.; Zhuo, R.-X.; Zhang, X.-Z. Self-Assembly of Hybridized
Peptide Nucleic Acid Amphiphiles. ACS Macro Lett. 2014, 3, 467−
471.
(529) Chalker, J. M.; Bernardes, J. L.; Davis, B. G. A “Tag-and-
Modify” Approach to Site-Selective Protein Modification. Acc. Chem.
Res. 2011, 44, 730−741.
(530) Behrendt, R.; White, P.; Offer, J. Advances in Fmoc Solid-
Phase Peptide Synthesis. J. Pept. Sci. 2016, 22, 4−27.
(531) Trads, J. B.; Tørring, T.; Gothelf, K. V. Site-Selective
Conjugation of Native Proteins with DNA. Acc. Chem. Res. 2017, 50,
1367−1374.
(532) Oyelaran, O.; Gildersleeve, J. C. Glycan Arrays: Recent
Advances and Future Challenges. Curr. Opin. Chem. Biol. 2009, 13,
406−413.
(533) Rosen, C. B.; Francis, M. B. Targeting the N Terminus for
Site-Selective Protein Modification. Nat. Chem. Biol. 2017, 13, 697−
705.
(534) van Hest, J. C. M.; Tirrell, D. A. Efficient Introduction of
Alkene Functionality into Proteins in Vivo. FEBS Lett. 1998, 428, 68−
70.
(535) Kiick, K. L.; Tirrell, D. A. Protein Engineering by In Vivo
Incorporation of Non-Natural Amino Acids: Control of Incorporation
of Methionine Analogues by Methionyl-TRNA Synthetase. Tetrahe-
dron 2000, 56, 9487−9493.
(536) Kiick, K. L.; Weberskirch, R.; Tirrell, D. A. Identification of an
Expanded Set of Translationally Active Methionine Analogues in
Escherichia Coli. FEBS Lett. 2001, 502, 25−30.
(537) Kiick, K. L.; Saxon, E.; Tirrell, D. A.; Bertozzi, C. R.
Incorporation of Azides into Recombinant Proteins for Chemo-
selective Modification by the Staudinger Ligation. Proc. Natl. Acad.
Sci. U. S. A. 2002, 99, 19−24.
(538) Prescher, J. A.; Dube, D. H.; Bertozzi, C. R. Chemical
Remodelling of Cell Surfaces in Living Animals. Nature 2004, 430,
873−877.
(539) Laughlin, S. T.; Bertozzi, C. R. Metabolic Labeling of Glycans
with Azido Sugars and Subsequent Glycan-Profiling and Visualization
via Staudinger Ligation. Nat. Protoc. 2007, 2, 2930−2944.
(540) Iwasaki, Y.; Matsunaga, A.; Fujii, S. Preparation of
Biointeractive Glycoprotein-Conjugated Hydrogels through Metabol-
ic Oligosacchalide Engineering. Bioconjugate Chem. 2014, 25, 1626−
1631.
(541) Wang, L.; Brock, A.; Herberich, B.; Schultz, P. G. Expanding
the Genetic Code of Escherichia Coli. Science 2001, 292, 498−500.
(542) Chin, J. W. Expanding and Reprogramming the Genetic Code.
Nature 2017, 550, 53−60.
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